| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | ARHGAP32 MYO9A RGPD1 ADGRB3 ARHGAP30 NF1 RGPD3 ARAP1 RGPD2 RIN1 ARHGAP12 RAPGEF2 USP6NL | 2.59e-05 | 279 | 233 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | formyltetrahydrofolate dehydrogenase activity | 1.36e-04 | 2 | 233 | 2 | GO:0016155 | |
| GeneOntologyMolecularFunction | arachidonate-CoA ligase activity | 2.41e-04 | 11 | 233 | 3 | GO:0047676 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 MYO9A RGPD1 ADGRB3 ARHGAP30 NF1 RGPD3 DENND5A ARAP1 CPEB2 RGPD2 RIN1 ARHGAP12 ITSN2 RAPGEF2 USP6NL | 3.21e-04 | 507 | 233 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 MYO9A RGPD1 ADGRB3 ARHGAP30 NF1 RGPD3 DENND5A ARAP1 CPEB2 RGPD2 RIN1 ARHGAP12 ITSN2 RAPGEF2 USP6NL | 3.21e-04 | 507 | 233 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO9A ATP11C ACSBG2 CHD6 DNHD1 KIF6 DDX17 SLC27A6 MYO1H KIF21A RNF213 MSH4 MSH6 IQCA1 POLQ FIGNL1 ACSL5 CDK7 | 3.34e-04 | 614 | 233 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.76e-04 | 188 | 233 | 9 | GO:0005201 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | PCSK5 ARHGAP32 HIP1 SEPTIN9 ADGRB3 PTPN22 CLASP2 ACTL6A BCL11A MAP3K1 EHD2 AP2M1 NF1 ALMS1 NRXN1 PTPRJ UBAP2L C3 PLCG2 DDHD2 QKI ADGRL3 CNTN1 ARAP1 SGIP1 PDCD6IP SLC25A4 ADCK1 IRX3 PDLIM4 ACE2 TRIM67 IFT88 IGHM RAPGEF2 TNXB | 1.74e-06 | 1366 | 233 | 36 | GO:0051130 |
| GeneOntologyBiologicalProcess | cell junction assembly | ERBB4 MYO9A ADGRB3 CLASP2 PTPRA NRXN1 PTPRJ GPC4 SDK1 ADGRL3 PDCD6IP ABI3BP PRICKLE1 SORBS1 IRX3 ACE2 SHANK2 TJP1 RAPGEF2 TNS1 | 7.88e-06 | 569 | 233 | 20 | GO:0034329 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ARHGAP32 MYO9A ADGRB3 LAMC3 CLASP2 BCL11A ST14 MAP3K1 GRXCR2 NRXN1 PTPRJ UBE3A PTPRQ PKHD1 UPK3A CNTN1 ARAP1 GP1BA HSPG2 PLOD3 ABI3BP PRICKLE1 BRSK2 PCDHAC2 SIN3A UST IFT88 IGHM ITSN2 RAPGEF2 FBLIM1 | 1.33e-05 | 1194 | 233 | 31 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | PCSK5 SPOCK1 CLASP2 ITGAM FAT2 PTPRA NF1 PTPRJ PKHD1 NPNT NID2 ABI3BP SORBS1 THBS3 P4HB TNXB | 1.86e-05 | 410 | 233 | 16 | GO:0031589 |
| GeneOntologyBiologicalProcess | cell junction organization | ERBB4 MYO9A ADGRB3 CLASP2 ITGAM PTPRA NF1 NRXN1 PTPRJ UBE3A GPC4 PKHD1 C3 SDK1 ADGRL3 PDCD6IP ABI3BP PRICKLE1 SORBS1 IRX3 ACE2 SHANK2 XIRP2 TJP1 RAPGEF2 TNS1 | 4.42e-05 | 974 | 233 | 26 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | ADGRB3 CLASP2 PTPRA NRXN1 PTPRJ GPC4 ADGRL3 ABI3BP PRICKLE1 IRX3 ACE2 TJP1 RAPGEF2 | 5.35e-05 | 309 | 233 | 13 | GO:1901888 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | PCSK5 CLASP2 ITGAM PTPRA NF1 PTPRJ PKHD1 NPNT NID2 SORBS1 THBS3 TNXB | 6.15e-05 | 270 | 233 | 12 | GO:0007160 |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 6.67e-05 | 20 | 233 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | RGPD1 PTPN22 KPNA6 PARP1 TAF8 NF1 RGPD3 SEC13 RGPD2 PRICKLE1 SIN3A UTP25 NUP188 IPO11 | 6.86e-05 | 362 | 233 | 14 | GO:0034504 |
| GeneOntologyBiologicalProcess | protein import into nucleus | RGPD1 PTPN22 KPNA6 NF1 RGPD3 SEC13 RGPD2 PRICKLE1 NUP188 IPO11 | 7.82e-05 | 195 | 233 | 10 | GO:0006606 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | PCSK5 VPS11 MAK SEPTIN9 ADGRB3 PTPN22 CLASP2 MAP3K1 PTPRA ALMS1 NRXN1 PTPRJ UBAP2L GPC4 PLCG2 ADGRL3 ARAP1 PDCD6IP ABI3BP PRICKLE1 IRX3 PDLIM4 ACE2 IFT88 TJP1 RAPGEF2 FBLIM1 HCFC1 USP6NL | 7.92e-05 | 1189 | 233 | 29 | GO:0044087 |
| GeneOntologyBiologicalProcess | maintenance of synapse structure | 8.40e-05 | 40 | 233 | 5 | GO:0099558 | |
| GeneOntologyBiologicalProcess | cell junction maintenance | 9.23e-05 | 65 | 233 | 6 | GO:0034331 | |
| GeneOntologyBiologicalProcess | peptide hormone processing | 9.48e-05 | 41 | 233 | 5 | GO:0016486 | |
| GeneOntologyBiologicalProcess | import into nucleus | RGPD1 PTPN22 KPNA6 NF1 RGPD3 SEC13 RGPD2 PRICKLE1 NUP188 IPO11 | 1.01e-04 | 201 | 233 | 10 | GO:0051170 |
| GeneOntologyBiologicalProcess | neuron development | CFH ARHGAP32 GLDN SPOCK1 MYO9A ADGRB3 LAMC3 CLASP2 BCL11A GRXCR2 NF1 ALMS1 NRXN1 UBE3A PTPRQ C3 DENND5A QKI SDK1 CNTN1 HSPG2 LRP12 ABI3BP PRICKLE1 BRSK2 PCDHAC2 SIN3A UST TRIM67 IFT88 ITSN2 RAPGEF2 TNXB | 1.11e-04 | 1463 | 233 | 33 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.14e-04 | 9 | 233 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | observational learning | 1.14e-04 | 9 | 233 | 3 | GO:0098597 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 1.20e-04 | 43 | 233 | 5 | GO:0071711 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 1.51e-04 | 71 | 233 | 6 | GO:0099084 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.61e-04 | 10 | 233 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | signaling receptor ligand precursor processing | 1.66e-04 | 46 | 233 | 5 | GO:0140448 | |
| GeneOntologyBiologicalProcess | endocytosis | HIP1 ITGAM EHD2 AP2M1 ALMS1 PTPRJ UBE3A PI4KB C3 PLCG2 CNN2 HSPG2 LRP12 SGIP1 MYO1H ACE2 RIN1 IGF2R MCTP1 IGHM ARHGAP12 ITSN2 | 1.84e-04 | 827 | 233 | 22 | GO:0006897 |
| GeneOntologyBiologicalProcess | import into cell | HIP1 ITGAM SLC29A2 EHD2 AP2M1 ALMS1 PTPRJ UBE3A PI4KB C3 CACNA1H PLCG2 CNN2 HSPG2 LRP12 SGIP1 SLC27A6 MYO1H ACE2 RIN1 IGF2R MCTP1 IGHM ARHGAP12 ITSN2 ACSL5 | 2.13e-04 | 1074 | 233 | 26 | GO:0098657 |
| GeneOntologyBiologicalProcess | epithelial cell morphogenesis | 2.24e-04 | 49 | 233 | 5 | GO:0003382 | |
| GeneOntologyBiologicalProcess | phospholipid biosynthetic process | ERBB4 AGPAT3 LPCAT4 HMGCS1 PI4KA PI4KB PLCG2 PI4KAP2 SLC44A1 TAMM41 ACSL5 | 2.48e-04 | 268 | 233 | 11 | GO:0008654 |
| GeneOntologyBiologicalProcess | basement membrane assembly | 2.90e-04 | 12 | 233 | 3 | GO:0070831 | |
| GeneOntologyBiologicalProcess | neuron projection development | ARHGAP32 SPOCK1 MYO9A ADGRB3 LAMC3 CLASP2 BCL11A GRXCR2 NF1 ALMS1 NRXN1 UBE3A DENND5A QKI SDK1 CNTN1 HSPG2 LRP12 ABI3BP PRICKLE1 BRSK2 PCDHAC2 SIN3A UST TRIM67 IFT88 ITSN2 RAPGEF2 TNXB | 2.97e-04 | 1285 | 233 | 29 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | PCSK5 SEPTIN9 ADGRB3 PTPN22 CLASP2 MAP3K1 NRXN1 PTPRJ UBAP2L PLCG2 ADGRL3 ARAP1 PDCD6IP IRX3 PDLIM4 ACE2 IFT88 | 3.53e-04 | 582 | 233 | 17 | GO:0044089 |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 3.55e-04 | 54 | 233 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | VPS11 MAK SEPTIN9 ALMS1 NRXN1 UBAP2L PDCD6IP ABI3BP PRICKLE1 IFT88 USP6NL | 3.61e-04 | 280 | 233 | 11 | GO:1902115 |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 3.74e-04 | 13 | 233 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | vertebrate eye-specific patterning | 3.78e-04 | 3 | 233 | 2 | GO:0150064 | |
| GeneOntologyBiologicalProcess | 10-formyltetrahydrofolate catabolic process | 3.78e-04 | 3 | 233 | 2 | GO:0009258 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | MMP21 CLASP2 COL22A1 NF1 PXDN ADAMTS20 NPNT HSPG2 NID2 PLOD3 ABI3BP PRICKLE1 TNXB | 3.79e-04 | 377 | 233 | 13 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | MMP21 CLASP2 COL22A1 NF1 PXDN ADAMTS20 NPNT HSPG2 NID2 PLOD3 ABI3BP PRICKLE1 TNXB | 3.89e-04 | 378 | 233 | 13 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | MMP21 CLASP2 COL22A1 NF1 PXDN ADAMTS20 NPNT HSPG2 NID2 PLOD3 ABI3BP PRICKLE1 TNXB | 3.99e-04 | 379 | 233 | 13 | GO:0045229 |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 4.72e-04 | 14 | 233 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | renal system development | CFH PCSK5 TET2 ERBB4 NF1 HOXD11 PKHD1 UPK3A NIPBL NPNT PRICKLE1 IRX3 IFT88 | 4.74e-04 | 386 | 233 | 13 | GO:0072001 |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 4.96e-04 | 58 | 233 | 5 | GO:0097106 | |
| GeneOntologyBiologicalProcess | cell junction disassembly | 5.02e-04 | 33 | 233 | 4 | GO:0150146 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 7.44e-05 | 8 | 234 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | cell-substrate junction | CLASP2 ERBIN PTPRA PI4KA CNN1 CNN2 HSPG2 FLT1 PDCD6IP SORBS1 IGF2R XIRP2 P4HB FBLIM1 TNS1 | 1.51e-04 | 443 | 234 | 15 | GO:0030055 |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.57e-04 | 10 | 234 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | extracellular matrix | MMP21 LAMC3 COL22A1 ERBIN PXDN GPC4 ADAMTS20 GP1BA NPNT GPC1 HSPG2 NID2 COL6A3 PLOD3 ABI3BP MUC5B THBS3 TNXB HCFC1 | 1.58e-04 | 656 | 234 | 19 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | MMP21 LAMC3 COL22A1 ERBIN PXDN GPC4 ADAMTS20 GP1BA NPNT GPC1 HSPG2 NID2 COL6A3 PLOD3 ABI3BP MUC5B THBS3 TNXB HCFC1 | 1.64e-04 | 658 | 234 | 19 | GO:0030312 |
| GeneOntologyCellularComponent | nuclear envelope | ERN1 AGPAT3 RGPD1 BCHE ERBIN PARP1 NRXN1 RGPD3 RBM15B SEC13 RGPD2 PRICKLE1 LBR IGF2R NUP188 SCAI IPO11 | 2.04e-04 | 560 | 234 | 17 | GO:0005635 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LAMC3 COL22A1 ERBIN PXDN GPC4 ADAMTS20 NPNT GPC1 HSPG2 NID2 COL6A3 PLOD3 ABI3BP THBS3 TNXB HCFC1 | 3.33e-04 | 530 | 234 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | actomyosin | 3.52e-04 | 117 | 234 | 7 | GO:0042641 | |
| GeneOntologyCellularComponent | focal adhesion | CLASP2 PTPRA PI4KA CNN1 CNN2 HSPG2 FLT1 PDCD6IP SORBS1 IGF2R XIRP2 P4HB FBLIM1 TNS1 | 3.80e-04 | 431 | 234 | 14 | GO:0005925 |
| GeneOntologyCellularComponent | annulate lamellae | 4.60e-04 | 14 | 234 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | actin cytoskeleton | ARHGAP32 VPS11 HIP1 MYO9A SEPTIN9 MAP3K1 CNN1 CNN2 FLT1 PDCD6IP MYO1H SORBS1 PDLIM4 XIRP2 TJP1 FBLIM1 | 8.16e-04 | 576 | 234 | 16 | GO:0015629 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | SEPTIN9 RGPD1 PTPN22 EHD2 TAF8 PI4KB RGPD3 PKHD1 PLCG2 COPS5 RGPD2 BRSK2 WBP2NL PDLIM4 USP2 THBS3 IGF2R IGHM CPEB4 RAPGEF2 FIGNL1 CDK7 | 8.45e-04 | 934 | 234 | 22 | GO:0048471 |
| GeneOntologyCellularComponent | nuclear pore | 9.65e-04 | 101 | 234 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 9.98e-04 | 18 | 234 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.30e-03 | 107 | 234 | 6 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.30e-03 | 107 | 234 | 6 | GO:0001725 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.37e-03 | 20 | 234 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | anchoring junction | CLASP2 ERBIN FAT2 PTPRA NRXN1 PTPRJ PI4KA CNN1 CNN2 ADGRL3 HSPG2 FLT1 PDCD6IP SORBS1 PDLIM4 IGF2R XIRP2 P4HB TJP1 RAPGEF2 FBLIM1 TNS1 | 1.48e-03 | 976 | 234 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.59e-03 | 21 | 234 | 3 | GO:0106068 | |
| Domain | FN3 | IGFN1 FNDC7 PTPRJ SDK1 CNTN1 COL6A3 ABI3BP TRIM67 CSF2RB TNXB HCFC1 | 1.76e-05 | 185 | 228 | 11 | SM00060 |
| Domain | FN3 | IGFN1 FNDC7 PTPRJ SDK1 CNTN1 COL6A3 ABI3BP TRIM67 CSF2RB TNXB HCFC1 | 3.47e-05 | 199 | 228 | 11 | PS50853 |
| Domain | FN3_dom | IGFN1 FNDC7 PTPRJ SDK1 CNTN1 COL6A3 ABI3BP TRIM67 CSF2RB TNXB HCFC1 | 5.42e-05 | 209 | 228 | 11 | IPR003961 |
| Domain | GCC2_Rab_bind | 6.06e-05 | 7 | 228 | 3 | IPR032023 | |
| Domain | Rab_bind | 6.06e-05 | 7 | 228 | 3 | PF16704 | |
| Domain | Sin3_C | 1.48e-04 | 2 | 228 | 2 | IPR031693 | |
| Domain | Sin3_corepress | 1.48e-04 | 2 | 228 | 2 | PF08295 | |
| Domain | HDAC_interact | 1.48e-04 | 2 | 228 | 2 | SM00761 | |
| Domain | 10_FTHF_DH | 1.48e-04 | 2 | 228 | 2 | IPR011407 | |
| Domain | Sin3a_C | 1.48e-04 | 2 | 228 | 2 | PF16879 | |
| Domain | HDAC_interact_dom | 1.48e-04 | 2 | 228 | 2 | IPR013194 | |
| Domain | fn3 | 1.73e-04 | 162 | 228 | 9 | PF00041 | |
| Domain | - | 2.02e-04 | 10 | 228 | 3 | 1.10.220.60 | |
| Domain | GRIP | 2.76e-04 | 11 | 228 | 3 | PF01465 | |
| Domain | Grip | 2.76e-04 | 11 | 228 | 3 | SM00755 | |
| Domain | Ran_BP1 | 3.64e-04 | 12 | 228 | 3 | PF00638 | |
| Domain | RANBD1 | 3.64e-04 | 12 | 228 | 3 | PS50196 | |
| Domain | GRIP | 3.64e-04 | 12 | 228 | 3 | PS50913 | |
| Domain | GRIP_dom | 3.64e-04 | 12 | 228 | 3 | IPR000237 | |
| Domain | PAH | 4.42e-04 | 3 | 228 | 2 | PS51477 | |
| Domain | - | 4.42e-04 | 3 | 228 | 2 | 3.10.25.10 | |
| Domain | Formyl_trans_C | 4.42e-04 | 3 | 228 | 2 | PF02911 | |
| Domain | Formyl_trans_C | 4.42e-04 | 3 | 228 | 2 | IPR005793 | |
| Domain | PAH | 4.42e-04 | 3 | 228 | 2 | IPR003822 | |
| Domain | - | 4.42e-04 | 3 | 228 | 2 | 1.20.1160.11 | |
| Domain | GART_AS | 4.42e-04 | 3 | 228 | 2 | IPR001555 | |
| Domain | PAH | 4.42e-04 | 3 | 228 | 2 | PF02671 | |
| Domain | GART | 4.42e-04 | 3 | 228 | 2 | PS00373 | |
| Domain | RanBD | 4.69e-04 | 13 | 228 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 4.69e-04 | 13 | 228 | 3 | IPR000156 | |
| Domain | EGF | 6.46e-04 | 235 | 228 | 10 | SM00181 | |
| Domain | Growth_fac_rcpt_ | 6.73e-04 | 156 | 228 | 8 | IPR009030 | |
| Domain | Laminin_G | 7.02e-04 | 58 | 228 | 5 | IPR001791 | |
| Domain | Rho_GTPase_activation_prot | 7.30e-04 | 88 | 228 | 6 | IPR008936 | |
| Domain | - | 8.76e-04 | 4 | 228 | 2 | 3.40.50.170 | |
| Domain | Formyl_transf_N | 8.76e-04 | 4 | 228 | 2 | IPR002376 | |
| Domain | MutS_II | 8.76e-04 | 4 | 228 | 2 | PF05188 | |
| Domain | DNA_mmatch_repair_MutS_con_dom | 8.76e-04 | 4 | 228 | 2 | IPR007860 | |
| Domain | CEBP_ZZ | 8.76e-04 | 4 | 228 | 2 | PF16366 | |
| Domain | RRM_7 | 8.76e-04 | 4 | 228 | 2 | PF16367 | |
| Domain | CEBP_ZZ | 8.76e-04 | 4 | 228 | 2 | IPR032296 | |
| Domain | Calponin/LIMCH1 | 8.76e-04 | 4 | 228 | 2 | IPR001997 | |
| Domain | Formyl_trans_N | 8.76e-04 | 4 | 228 | 2 | PF00551 | |
| Domain | RA | 9.38e-04 | 36 | 228 | 4 | PF00788 | |
| Domain | RhoGAP | 9.54e-04 | 62 | 228 | 5 | SM00324 | |
| Domain | EGF-like_dom | 1.01e-03 | 249 | 228 | 10 | IPR000742 | |
| Domain | RhoGAP | 1.03e-03 | 63 | 228 | 5 | PF00620 | |
| Domain | RA | 1.04e-03 | 37 | 228 | 4 | PS50200 | |
| Domain | RhoGAP_dom | 1.10e-03 | 64 | 228 | 5 | IPR000198 | |
| Domain | - | 1.10e-03 | 64 | 228 | 5 | 1.10.555.10 | |
| Domain | RHOGAP | 1.10e-03 | 64 | 228 | 5 | PS50238 | |
| Domain | RA_dom | 1.40e-03 | 40 | 228 | 4 | IPR000159 | |
| Domain | MUTSd | 1.45e-03 | 5 | 228 | 2 | SM00533 | |
| Domain | MUTSac | 1.45e-03 | 5 | 228 | 2 | SM00534 | |
| Domain | MutS_IV | 1.45e-03 | 5 | 228 | 2 | PF05190 | |
| Domain | MutS_III | 1.45e-03 | 5 | 228 | 2 | PF05192 | |
| Domain | DNA_mismatch_repair_MutS_C | 1.45e-03 | 5 | 228 | 2 | IPR000432 | |
| Domain | ACP_DOMAIN | 1.45e-03 | 5 | 228 | 2 | PS50075 | |
| Domain | MutS_V | 1.45e-03 | 5 | 228 | 2 | PF00488 | |
| Domain | - | 1.45e-03 | 5 | 228 | 2 | 1.10.1200.10 | |
| Domain | DNA_mismatch_repair_MutS_clamp | 1.45e-03 | 5 | 228 | 2 | IPR007861 | |
| Domain | DNA_MISMATCH_REPAIR_2 | 1.45e-03 | 5 | 228 | 2 | PS00486 | |
| Domain | PHOSPHOPANTETHEINE | 1.45e-03 | 5 | 228 | 2 | PS00012 | |
| Domain | Formyl_transferase_C-like | 1.45e-03 | 5 | 228 | 2 | IPR011034 | |
| Domain | PP-binding | 1.45e-03 | 5 | 228 | 2 | PF00550 | |
| Domain | DNA_mismatch_repair_MutS_core | 1.45e-03 | 5 | 228 | 2 | IPR007696 | |
| Domain | GLYPICAN | 2.15e-03 | 6 | 228 | 2 | PS01207 | |
| Domain | Calponin_repeat | 2.15e-03 | 6 | 228 | 2 | IPR000557 | |
| Domain | Glypican | 2.15e-03 | 6 | 228 | 2 | IPR001863 | |
| Domain | GF_recep_IV | 2.15e-03 | 6 | 228 | 2 | PF14843 | |
| Domain | SPOC_C | 2.15e-03 | 6 | 228 | 2 | IPR012921 | |
| Domain | CALPONIN_1 | 2.15e-03 | 6 | 228 | 2 | PS01052 | |
| Domain | Glypican | 2.15e-03 | 6 | 228 | 2 | PF01153 | |
| Domain | SPOC | 2.15e-03 | 6 | 228 | 2 | PF07744 | |
| Domain | Calponin | 2.15e-03 | 6 | 228 | 2 | PF00402 | |
| Domain | GF_recep_IV | 2.15e-03 | 6 | 228 | 2 | IPR032778 | |
| Domain | Glypican_CS | 2.15e-03 | 6 | 228 | 2 | IPR019803 | |
| Domain | CALPONIN_2 | 2.15e-03 | 6 | 228 | 2 | PS51122 | |
| Domain | PP-bd_ACP | 2.15e-03 | 6 | 228 | 2 | IPR009081 | |
| Pubmed | ARHGAP32 RGPD1 ADGRB3 TNRC6B CLASP2 BCL11A ERBIN PARP1 NF1 NRXN1 UBE3A UBAP2L PI4KA RGPD3 NIPBL CNTN1 RGPD2 SIN3B SGIP1 PDCD6IP FOXP2 KIF21A HECTD4 DIDO1 SORBS1 IGF2R TRIM67 SHANK2 TJP1 KIAA1217 RAPGEF2 TNS1 | 2.05e-13 | 963 | 239 | 32 | 28671696 | |
| Pubmed | ARHGAP32 MYO9A SEPTIN9 CLASP2 BCL11A ALDH1L1 MDH1 ERBIN PARP1 AP2M1 PTPRA NF1 UBAP2L PI4KA EIF3L USP7 CNTN1 SEC13 GPC1 CPEB2 DDX17 SGIP1 PDCD6IP SLC25A4 BRSK2 SORBS1 RIN1 SLC44A1 SHANK2 P4HB TJP1 KIAA1217 IGHM CPEB4 ITSN2 RAPGEF2 TNS1 SCAI | 9.34e-13 | 1431 | 239 | 38 | 37142655 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 ARHGAP32 ERBB4 SF3B4 HIVEP2 MYO9A CLASP2 ERBIN FSIP2 NF1 ALMS1 MTUS1 PI4KA PI4KB PDCD6IP NELFCD BRSK2 SORBS1 LBR KIAA1191 C2CD3 TJP1 KIAA1217 RAPGEF2 PCDH7 USP6NL | 3.40e-10 | 861 | 239 | 26 | 36931259 |
| Pubmed | ARHGAP32 ERBB4 SEPTIN9 RGPD1 ADGRB3 TNRC6B HMGCS1 ERBIN AP2M1 NF1 NRXN1 UBE3A UBAP2L PI4KA RGPD3 USP7 ADGRL3 RGPD2 DDX17 SGIP1 PDCD6IP ADCK1 BRSK2 SORBS1 SHANK2 P4HB TJP1 KIAA1217 CPEB4 ELP4 | 3.57e-10 | 1139 | 239 | 30 | 36417873 | |
| Pubmed | SPOCK1 RGPD1 LPCAT4 MMP21 ERBIN PARP1 AP2M1 PXDN NRXN1 RGPD3 GPC4 PKHD1 ATP11C CHD6 POFUT2 NIPBL RGPD2 DDX17 ABI3BP SLC25A4 NELFCD PCDHGA10 PCDHGA2 KIF21A C2CD3 TRIM67 SHANK2 IFT88 BAZ1A P4HB TJP1 ARHGAP12 ITSN2 POLQ | 3.89e-10 | 1442 | 239 | 34 | 35575683 | |
| Pubmed | TET2 ARHGAP32 PSMA4 RGPD1 TNRC6B ACTL6A BCL11A ERBIN HOXB9 TAF8 AP2M1 ALMS1 HOXD11 UBAP2L EIF3L USP7 CHD6 QKI NIPBL SEC13 HSPG2 SIN3B FOXP2 DIDO1 SIN3A LBR ZNF3 P4HB ZBTB10 RBM6 TAF5L PCDH7 HCFC1 | 1.22e-09 | 1429 | 239 | 33 | 35140242 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MAGEA4 HIP1 SF3B4 SEPTIN9 PSMA4 HMGCS1 ACTL6A MDH1 ITGAM ERBIN PARP1 AP2M1 MTUS1 UBAP2L QKI NMT1 CNN2 SIN3B DDX17 PDCD6IP APMAP KIF21A RNF213 MUC5B SIN3A PDLIM4 MSH6 IGF2R P4HB TJP1 HCFC1 IPO11 | 1.61e-09 | 1367 | 239 | 32 | 32687490 |
| Pubmed | SF3B4 SEPTIN9 PSMA4 LAMC3 KPNA6 PARP1 AP2M1 PXDN UBAP2L EIF3L C3 POFUT2 NIPBL CNN2 ALPI GPC1 DDX17 PLOD3 PDCD6IP KIF21A DIDO1 LBR IGF2R TAMM41 BAZ1A P4HB TJP1 NUP188 HCFC1 CDK7 | 7.18e-09 | 1297 | 239 | 30 | 33545068 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SF3B4 SPOCK1 TNRC6B MRPL19 ACTL6A PARP1 AP2M1 NRXN1 GPC4 USP7 RBM15B CHD6 NIPBL DDX17 PDCD6IP SLC25A4 APMAP HECTD4 DIDO1 LBR MSH6 P4HB TJP1 CPEB4 RBM6 TAF5L TNXB | 9.07e-09 | 1082 | 239 | 27 | 38697112 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SEPTIN9 PTPN22 KPNA6 CLASP2 ACTL6A ALDH1L1 GTF3C4 HOXD11 USP7 COPS5 FLT1 PLOD3 SORBS1 RPIA XIRP2 GALNT5 HCFC1 IPO11 | 1.31e-08 | 497 | 239 | 18 | 36774506 |
| Pubmed | CFH TET2 SF3B4 HIVEP2 ADGRB3 KPNA6 MDH1 GTF3C4 PARP1 AP2M1 PTPRA UBE3A USP7 CHD6 ZNF841 MBD4 QKI COPS5 NIPBL KIF21A HECTD4 SORBS1 REV3L USP2 IFT88 TJP1 RAPGEF2 SCAI | 8.23e-08 | 1285 | 239 | 28 | 35914814 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | GTF3C4 PARP1 UBAP2L USP7 NIPBL DDX17 PDCD6IP RNF213 DIDO1 SIN3A MSH6 BAZ1A P4HB HCFC1 | 8.91e-08 | 332 | 239 | 14 | 32786267 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CFH ALDH1L1 MDH1 ITGAM PXDN PTPRJ PIGR ALDH1L2 C3 UPK3A CA1 CNTN1 GP1BA HSPG2 NID2 COL6A3 PDCD6IP STEAP4 SI MUC5B ACE2 IGF2R IGHM FIGNL1 TNXB | 1.17e-07 | 1070 | 239 | 25 | 23533145 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | VPS13C PSMA4 LAMC3 KPNA6 CLASP2 ACTL6A MDH1 PARP1 AP2M1 NF1 UBAP2L PI4KA EIF3L USP7 RBM15B NIPBL DNHD1 DDX17 PDCD6IP APMAP LBR MSH6 IGF2R BAZ1A P4HB NUP188 TAF5L GALNT5 HCFC1 | 1.99e-07 | 1425 | 239 | 29 | 30948266 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TET2 HIP1 ERN1 CARHSP1 SEPTIN9 TNRC6B HMGCS1 ERBIN POFUT2 NIPBL SORBS1 LBR P4HB KIAA1217 RBM6 FBLIM1 IPO11 | 2.22e-07 | 536 | 239 | 17 | 15840001 |
| Pubmed | TET2 HIP1 ERN1 CARHSP1 SEPTIN9 TNRC6B HMGCS1 ERBIN POFUT2 NIPBL SORBS1 LBR P4HB KIAA1217 RBM6 FBLIM1 IPO11 | 2.34e-07 | 538 | 239 | 17 | 10512203 | |
| Pubmed | ERBB4 LPCAT4 TNRC6B MMP21 KPNA6 ACTL6A BCL11A TAF8 ALMS1 MTUS1 USP7 NID2 FOXP2 RNF213 SIN3A LBR REV3L MSH6 MCTP1 UTP25 CPEB4 ZBTB10 NUP188 TAF5L RAPGEF2 | 2.57e-07 | 1116 | 239 | 25 | 31753913 | |
| Pubmed | ARHGAP32 SEPTIN9 TNRC6B ERBIN ALMS1 SIN3B LBR P4HB TJP1 KIAA1217 CPEB4 USP6NL | 3.27e-07 | 263 | 239 | 12 | 34702444 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | MAGEA4 CARHSP1 TNRC6B CLASP2 ALDH1L1 MDH1 EHD2 FSIP2 PARP1 AP2M1 SEC13 SLC25A4 KIF21A SORBS1 PDLIM4 RPIA P4HB | 3.89e-07 | 558 | 239 | 17 | 35063084 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | MAK SF3B4 ERN1 UBL4A ALMS1 PIGR UBAP2L USP7 CACNA1H SEC13 FLT1 PDCD6IP DIDO1 LBR SHANK2 DAW1 ARHGAP12 NUP188 CDK7 | 4.13e-07 | 695 | 239 | 19 | 23602568 |
| Pubmed | HIP1 TNRC6B CLASP2 ERBIN TAF8 PXDN PI4KA RGPD3 EIF3L USP7 RBM15B CHD6 MBD4 NMT1 NIPBL SEC13 SIN3B PLOD3 DIDO1 MSH6 SHANK2 UTP25 BAZ1A P4HB ITSN2 RBM6 TAF5L USP6NL CDK7 | 5.47e-07 | 1497 | 239 | 29 | 31527615 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | VPS13C PSMA4 ALDH1L1 MDH1 EHD2 AP2M1 PTPRJ PIGR PKHD1 UPK3A NIPBL SEC13 DNHD1 HSPG2 COL6A3 PLOD3 PDCD6IP SLC3A1 ACE2 SLC44A1 IGF2R ITSN2 FIGNL1 | 6.65e-07 | 1016 | 239 | 23 | 19056867 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | RGPD1 CLASP2 RGPD3 GPC4 QKI GPC1 RGPD2 SGIP1 SORBS1 PDLIM4 SHANK2 | 6.70e-07 | 231 | 239 | 11 | 16452087 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCSK5 HIP1 HIVEP2 UBL4A LAMC3 CLASP2 SLC35E2B SLC29A2 ST14 PI4KA USP7 CACNA1H DENND5A ARAP1 HSPG2 PLOD3 HECTD4 AKNA REV3L C2CD3 IGF2R SHANK2 NUP188 HCFC1 | 7.81e-07 | 1105 | 239 | 24 | 35748872 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAGEA4 MYO9A SEPTIN9 PSMA4 ACTL6A ERBIN GTF3C4 PARP1 AP2M1 ADPRS NF1 UBE3A PI4KA EIF3L USP7 PLCG2 NIPBL GPC1 DDX17 PDCD6IP KIF21A LBR RIN1 MSH6 BAZ1A P4HB ZBTB10 | 7.90e-07 | 1353 | 239 | 27 | 29467282 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 8.39e-07 | 146 | 239 | 9 | 23892456 | |
| Pubmed | HIP1 SF3B4 SEPTIN9 KPNA6 ERBIN PARP1 AP2M1 PI4KA USP7 SEC13 GPC1 DDX17 PLOD3 UTP25 BAZ1A TJP1 NUP188 USP6NL | 8.70e-07 | 660 | 239 | 18 | 32780723 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | HMGCS1 ITGAM PARP1 UBAP2L USP7 C3 PLCG2 NMT1 DDX17 PDCD6IP UTP25 HCFC1 IPO11 | 8.93e-07 | 344 | 239 | 13 | 30333137 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | SEPTIN9 ADGRB3 TNRC6B CLASP2 MDH1 NF1 UBAP2L PI4KA C3 CHD6 SEC13 GPC1 SIN3B ARHGAP12 RAPGEF2 | 1.23e-06 | 475 | 239 | 15 | 31040226 |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.24e-06 | 153 | 239 | 9 | 26365490 | |
| Pubmed | Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase. | 1.28e-06 | 4 | 239 | 3 | 19411110 | |
| Pubmed | 1.48e-06 | 116 | 239 | 8 | 21549307 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.60e-06 | 203 | 239 | 10 | 22083510 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SF3B4 SEPTIN9 PSMA4 TNRC6B KPNA6 CLASP2 MDH1 PARP1 AP2M1 UBAP2L EIF3L USP7 NMT1 NIPBL CNN2 SEC13 DDX17 PLOD3 PDCD6IP SLC25A4 KIF21A DIDO1 SIN3A MSH6 P4HB TJP1 HCFC1 | 1.84e-06 | 1415 | 239 | 27 | 28515276 |
| Pubmed | 1.90e-06 | 257 | 239 | 11 | 16335952 | ||
| Pubmed | SEPTIN9 TNRC6B MDH1 PARP1 ALMS1 UBAP2L EIF3L USP7 CNN2 SEC13 DDX17 PDCD6IP P4HB RBM6 HCFC1 | 1.99e-06 | 494 | 239 | 15 | 26831064 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | MAGEA4 CARHSP1 TNRC6B KPNA6 UBAP2L RGPD3 EIF3L PDCD6IP SORBS1 LBR PDLIM4 MSH6 | 2.17e-06 | 315 | 239 | 12 | 26777405 |
| Pubmed | KPNA6 ACTL6A ERBIN GTF3C4 PARP1 AP2M1 PIGR PI4KA USP7 MBD4 COPS5 PLOD3 MUC5B RIN1 MSH6 IGF2R NUP188 | 2.22e-06 | 634 | 239 | 17 | 34591612 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SEPTIN9 PSMA4 TNRC6B ERBIN GTF3C4 PARP1 AP2M1 ALMS1 UBAP2L USP7 NMT1 NIPBL SIN3B DDX17 DIDO1 SIN3A MSH6 BAZ1A TJP1 KIAA1217 HCFC1 | 2.31e-06 | 934 | 239 | 21 | 33916271 |
| Pubmed | Roles for phagocytic cells and complement in controlling relapsing fever infection. | 3.17e-06 | 5 | 239 | 3 | 19458267 | |
| Pubmed | 3.49e-06 | 130 | 239 | 8 | 12421765 | ||
| Pubmed | 3.76e-06 | 175 | 239 | 9 | 28071719 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 4.63e-06 | 135 | 239 | 8 | 31077711 | |
| Pubmed | SF3B4 VPS13C ACTL6A COL22A1 MDH1 PARP1 PI4KA USP7 CHD6 PLCG2 SEC13 DDX17 PDCD6IP SLC25A4 DIDO1 P4HB RBM6 GALNT5 | 5.57e-06 | 754 | 239 | 18 | 35906200 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ACTL6A GTF3C4 FSIP2 PARP1 HOXB9 USP7 CHD6 MBD4 NIPBL SIN3B DIDO1 SIN3A MSH6 BAZ1A ZBTB10 HCFC1 | 5.61e-06 | 608 | 239 | 16 | 36089195 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SF3B4 RGPD1 KPNA6 CLASP2 ACTL6A GTF3C4 AP2M1 PIGR RGPD3 EIF3L COPS5 NIPBL ARAP1 SEC13 RGPD2 DDX17 PDCD6IP SLC25A4 P4HB TJP1 ITSN2 NUP188 HCFC1 | 5.63e-06 | 1155 | 239 | 23 | 20360068 |
| Pubmed | PSMA4 TNRC6B ERBIN USP7 COPS5 PLOD3 PDCD6IP DIDO1 LBR RIN1 IGF2R BAZ1A ELP4 CDK7 | 5.73e-06 | 472 | 239 | 14 | 38943005 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 6.13e-06 | 38 | 239 | 5 | 12791264 | |
| Pubmed | 6.31e-06 | 6 | 239 | 3 | 31992794 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | PSMA4 RGPD1 TNRC6B UBL4A KPNA6 ACTL6A GTF3C4 PARP1 AP2M1 UBE3A RGPD3 USP7 COPS5 SEC13 RGPD2 DDX17 SLC25A4 APMAP COX15 LBR MSH6 P4HB NUP188 HCFC1 | 7.07e-06 | 1257 | 239 | 24 | 37317656 |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | ERBB4 MYO9A PSMA4 PARP1 PTPRA NF1 UBAP2L CHD6 PRICKLE1 SLC3A1 SHANK2 KIAA1217 ELP4 | 7.89e-06 | 420 | 239 | 13 | 28065597 |
| Pubmed | PSMA4 MDH1 GTF3C4 EHD2 PARP1 AP2M1 UBE3A EIF3L USP7 MED26 MBD4 NIPBL PDCD6IP NELFCD RNF213 DIDO1 SIN3A MSH6 BAZ1A HCFC1 CDK7 | 8.14e-06 | 1014 | 239 | 21 | 32416067 | |
| Pubmed | TET2 SEPTIN9 PSMA4 PTPN22 HMGCS1 ACTL6A BCL11A PARP1 AP2M1 QKI COPS5 NIPBL SIN3B DDX17 DIDO1 SIN3A ZNF3 MSH6 TAF5L HCFC1 IPO11 CDK7 | 8.86e-06 | 1103 | 239 | 22 | 34189442 | |
| Pubmed | SF3B4 PSMA4 PARP1 MED26 QKI NIPBL PADI1 SEC13 DDX17 PDLIM4 IGF2R P4HB IGHM | 8.94e-06 | 425 | 239 | 13 | 24999758 | |
| Pubmed | ARHGAP32 MYO9A SEPTIN9 PSMA4 TNRC6B ERBIN PARP1 UBAP2L DDX17 PDCD6IP APMAP LBR IGF2R ARHGAP12 PCDH7 HCFC1 USP6NL | 9.46e-06 | 708 | 239 | 17 | 39231216 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ARHGAP32 SEPTIN9 ERBIN PTPRJ PI4KA CNN2 SORBS1 LBR IGF2R SHANK2 TJP1 KIAA1217 HCFC1 USP6NL ELP4 | 9.96e-06 | 565 | 239 | 15 | 25468996 |
| Pubmed | ERBB4 LPCAT4 NF1 DIO2 CACNA1H NMT1 SDK1 SEC13 DDX17 SLC25A4 SHANK2 TJP1 ARHGAP12 ITSN2 RAPGEF2 | 1.06e-05 | 568 | 239 | 15 | 9110174 | |
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 9037092 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 21205196 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 24403063 | ||
| Pubmed | Epithelial endoplasmic reticulum stress orchestrates a protective IgA response. | 1.10e-05 | 7 | 239 | 3 | 30819965 | |
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 23536549 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 12191015 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 22821000 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.10e-05 | 7 | 239 | 3 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.10e-05 | 7 | 239 | 3 | 11353387 | |
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 30944974 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.10e-05 | 7 | 239 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.10e-05 | 7 | 239 | 3 | 17372272 | |
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 38657106 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 18949001 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 25187515 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 8603673 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 26632511 | ||
| Pubmed | Systemic cancer therapy with engineered adenovirus that evades innate immunity. | 1.10e-05 | 7 | 239 | 3 | 33239388 | |
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 23818861 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 20682751 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | UBL4A KPNA6 HMGCS1 ACTL6A GTF3C4 AP2M1 PI4KA EIF3L USP7 COPS5 SEC13 APMAP LBR IGF2R NUP188 | 1.13e-05 | 571 | 239 | 15 | 37167062 |
| Pubmed | A "double adaptor" method for improved shotgun library construction. | ERBB4 LPCAT4 NF1 DIO2 CACNA1H NMT1 SDK1 SEC13 DDX17 SLC25A4 SHANK2 TJP1 ARHGAP12 ITSN2 RAPGEF2 | 1.20e-05 | 574 | 239 | 15 | 8619474 |
| Pubmed | SEPTIN9 PARP1 PTPRA PI4KB GPC4 USP7 PLOD3 PDCD6IP BRSK2 COX15 XIRP2 P4HB TJP1 | 1.20e-05 | 437 | 239 | 13 | 20562859 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | KPNA6 ACTL6A GTF3C4 PARP1 NF1 UBAP2L PLOD3 HECTD4 MSH6 UTP25 ZBTB10 RBM6 NUP188 | 1.29e-05 | 440 | 239 | 13 | 34244565 |
| Pubmed | ARHGAP32 SF3B4 PTPN22 KPNA6 CLASP2 ERBIN PARP1 PTPRA PTPRJ MTUS1 PI4KA USP7 PLOD3 RNF213 MSH6 C2CD3 IGF2R P4HB TJP1 TNS1 PCDH7 | 1.35e-05 | 1049 | 239 | 21 | 27880917 | |
| Pubmed | NF1 UBAP2L EIF3L USP7 NIPBL SEC13 PDCD6IP DIDO1 MSH6 IGF2R UTP25 P4HB TJP1 RBM6 NUP188 HCFC1 | 1.36e-05 | 653 | 239 | 16 | 22586326 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SEPTIN9 TNRC6B GTF3C4 PARP1 PIGR UBAP2L RGPD3 USP7 MED26 PDLIM4 TJP1 HCFC1 CDK7 | 1.42e-05 | 444 | 239 | 13 | 34795231 |
| Pubmed | SF3B4 PSMA4 ACTL6A PARP1 RGPD3 ADAMTS20 CACNA1H COL6A3 DDX17 PLOD3 FOXP2 P4HB KIAA1217 HCFC1 | 1.46e-05 | 513 | 239 | 14 | 25798074 | |
| Pubmed | 1.57e-05 | 209 | 239 | 9 | 36779422 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.75e-05 | 8 | 239 | 3 | 21670213 | |
| Pubmed | 1.75e-05 | 8 | 239 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.75e-05 | 8 | 239 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.75e-05 | 8 | 239 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.75e-05 | 8 | 239 | 3 | 28745977 | |
| Pubmed | RGPD1 UBL4A KPNA6 ACTL6A ERBIN PARP1 DDX17 PLOD3 TAF5L HCFC1 IPO11 CDK7 | 1.87e-05 | 390 | 239 | 12 | 17643375 | |
| Pubmed | SF3B4 SEPTIN9 PSMA4 TNRC6B CLASP2 HMGCS1 ACTL6A ERBIN PARP1 HOXB9 AP2M1 USP7 MED26 SEC13 GPC1 DDX17 PLOD3 PDCD6IP KIF21A LBR P4HB TJP1 HCFC1 | 1.91e-05 | 1247 | 239 | 23 | 27684187 | |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 1.93e-05 | 119 | 239 | 7 | 35776542 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | SEPTIN9 RGPD1 GTF3C4 PARP1 RGPD2 SIN3B DIDO1 SIN3A MSH6 HCFC1 | 2.03e-05 | 271 | 239 | 10 | 32433965 |
| Pubmed | AGPAT3 LPCAT4 KPNA6 CLASP2 PARP1 NF1 PI4KA EIF3L CNN2 DDX17 PDCD6IP NELFCD APMAP AKNA RNF213 LBR SLC44A1 IGF2R NUP188 HCFC1 HECA ACSL5 | 2.13e-05 | 1168 | 239 | 22 | 19946888 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MAGEA4 SF3B4 SEPTIN9 ACTL6A GTF3C4 PARP1 AP2M1 EIF3L USP7 RBM15B C3 NMT1 SEC13 GPC1 DDX17 PLOD3 PDCD6IP DIDO1 MSH6 P4HB TJP1 KIAA1217 CDK7 | 2.16e-05 | 1257 | 239 | 23 | 36526897 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 2.28e-05 | 219 | 239 | 9 | 31353912 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.36e-05 | 220 | 239 | 9 | 35785414 | |
| Interaction | KCTD13 interactions | ARHGAP32 MYO9A SEPTIN9 CLASP2 BCL11A ALDH1L1 MDH1 ERBIN PARP1 AP2M1 PTPRA NF1 UBAP2L PI4KA EIF3L USP7 CNTN1 SEC13 GPC1 CPEB2 DDX17 SGIP1 PDCD6IP SLC25A4 BRSK2 SORBS1 RIN1 SLC44A1 SHANK2 P4HB TJP1 KIAA1217 CPEB4 ITSN2 RAPGEF2 TNS1 SCAI | 1.78e-06 | 1394 | 233 | 37 | int:KCTD13 |
| Interaction | AR interactions | TET2 VPS13C ACTL6A GTF3C4 PARP1 TAF8 UBE3A UBAP2L USP7 PLCG2 DENND5A NIPBL SEC13 SIN3B DDX17 SLC25A4 NELFCD HECTD4 RNF213 DIDO1 SIN3A USP2 TJP1 KIAA1217 ZBTB10 NUP188 TNS1 HCFC1 CDK7 | 4.29e-06 | 992 | 233 | 29 | int:AR |
| Interaction | CDKL5 interactions | 6.66e-06 | 113 | 233 | 9 | int:CDKL5 | |
| Interaction | RNF43 interactions | ARHGAP32 SEPTIN9 TNRC6B UBL4A ERBIN ALMS1 QKI SEC13 SIN3B DDX17 LBR P4HB TJP1 KIAA1217 CPEB4 NUP188 USP6NL | 1.06e-05 | 427 | 233 | 17 | int:RNF43 |
| Interaction | FBXO22 interactions | SEPTIN9 PTPN22 KPNA6 CLASP2 ACTL6A ALDH1L1 GTF3C4 HOXD11 USP7 COPS5 FLT1 PLOD3 SORBS1 RPIA TRIM67 XIRP2 GALNT5 HCFC1 IPO11 | 1.81e-05 | 540 | 233 | 19 | int:FBXO22 |
| Interaction | YWHAG interactions | TET2 ARHGAP32 SF3B4 HIVEP2 MYO9A CLASP2 ERBIN MAP3K1 NF1 ALMS1 MTUS1 UBE3A PI4KA PI4KB RBM15B COPS5 DDX17 PDCD6IP NELFCD HECTD4 SORBS1 LBR RIN1 C2CD3 TRIM67 BAZ1A P4HB TJP1 RAPGEF2 PCDH7 USP6NL CDK7 | 1.93e-05 | 1248 | 233 | 32 | int:YWHAG |
| Interaction | TNXB interactions | 2.15e-05 | 15 | 233 | 4 | int:TNXB | |
| Interaction | GRB2 interactions | CFH ARHGAP32 ERBB4 SF3B4 PTPN22 CLASP2 ACTL6A MAP3K1 PARP1 AP2M1 PTPRA PTPRJ PLCG2 COPS5 ARAP1 HSPG2 FLT1 DDX17 PDCD6IP ABI3BP PRR22 TRIM67 ARHGAP12 USP6NL | 2.27e-05 | 806 | 233 | 24 | int:GRB2 |
| Interaction | YWHAZ interactions | TET2 ARHGAP32 HIVEP2 MYO9A CLASP2 ERBIN MAP3K1 FSIP2 PTPRA NF1 NRXN1 MTUS1 UBE3A PI4KB C3 COPS5 GP1BA NELFCD HECTD4 SORBS1 LBR SLC3A1 ACE2 RIN1 TRIM67 MCTP1 CSF2RB TJP1 RAPGEF2 TNS1 PCDH7 USP6NL CDK7 | 2.32e-05 | 1319 | 233 | 33 | int:YWHAZ |
| Interaction | SORBS3 interactions | ARAP1 CPEB2 DDX17 PLOD3 SORBS1 RIN1 USP2 TRIM67 KIAA1217 TNS1 CDK7 | 2.44e-05 | 202 | 233 | 11 | int:SORBS3 |
| Interaction | MECP2 interactions | SF3B4 SPOCK1 TNRC6B MRPL19 ACTL6A PARP1 AP2M1 NRXN1 GPC4 USP7 RBM15B CHD6 NIPBL SIN3B DDX17 PDCD6IP SLC25A4 APMAP HECTD4 DIDO1 SIN3A LBR MSH6 TRIM67 BAZ1A P4HB TJP1 CPEB4 RBM6 TAF5L TNXB CDK7 | 3.52e-05 | 1287 | 233 | 32 | int:MECP2 |
| Interaction | AGTR2 interactions | 3.68e-05 | 17 | 233 | 4 | int:AGTR2 | |
| Interaction | EED interactions | VPS11 HIP1 VPS13C SEPTIN9 KPNA6 BCL11A GTF3C4 PARP1 AP2M1 PXDN PIGR EIF3L USP7 NIPBL HSPG2 NID2 DDX17 PLOD3 PDCD6IP SLC25A4 COX15 DIDO1 SALL4 SIN3A LBR MSH6 IGF2R TRIM67 XIRP2 BAZ1A TJP1 ITSN2 NUP188 HCFC1 | 5.93e-05 | 1445 | 233 | 34 | int:EED |
| GeneFamily | Fibronectin type III domain containing | IGFN1 FNDC7 PTPRJ PTPRQ SDK1 CNTN1 ABI3BP TRIM67 CSF2RB TNXB | 2.14e-06 | 160 | 165 | 10 | 555 |
| GeneFamily | MutS homologs|PWWP domain containing | 8.13e-04 | 5 | 165 | 2 | 1026 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 8.80e-04 | 21 | 165 | 3 | 813 | |
| GeneFamily | Glypicans | 1.21e-03 | 6 | 165 | 2 | 572 | |
| GeneFamily | Acyl-CoA synthetase family | 1.66e-03 | 26 | 165 | 3 | 40 | |
| GeneFamily | LIM domain containing | 2.06e-03 | 59 | 165 | 4 | 1218 | |
| Coexpression | NABA_CORE_MATRISOME | GLDN SPOCK1 LAMC3 COL22A1 FNDC7 PXDN NPNT HSPG2 NID2 COL6A3 ABI3BP THBS3 TNXB | 1.05e-06 | 270 | 234 | 13 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | GLDN SPOCK1 LAMC3 COL22A1 FNDC7 PXDN NPNT HSPG2 NID2 COL6A3 ABI3BP THBS3 TNXB | 1.29e-06 | 275 | 234 | 13 | M5884 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_DN | CARHSP1 BCHE ALDH1L1 EHD2 UBE3A QKI HSPG2 NID2 PDCD6IP SORBS1 TNS1 | 2.21e-06 | 202 | 234 | 11 | M12428 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_DN | CARHSP1 BCHE ALDH1L1 EHD2 UBE3A QKI HSPG2 NID2 PDCD6IP SORBS1 TNS1 | 2.80e-06 | 207 | 234 | 11 | MM988 |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 2.84e-06 | 131 | 234 | 9 | M39232 | |
| Coexpression | SABATES_COLORECTAL_ADENOMA_DN | CFH GLDN BCHE NRXN1 CNN1 CA1 ALPI ABI3BP SI USP2 IGHM TNS1 PCDH7 | 3.25e-06 | 299 | 234 | 13 | M14791 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | CFH ADGRB3 LAMC3 EHD2 PXDN QKI ADGRL3 COL6A3 FLT1 SGIP1 ABI3BP STEAP4 PDLIM4 GIMAP8 MCTP1 XIRP2 TNS1 | 3.35e-06 | 505 | 234 | 17 | M39167 |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 6.45e-06 | 30 | 234 | 5 | M47990 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | IGFN1 SPOCK1 LPCAT4 BCL11A FSIP2 FAT2 NRXN1 MTUS1 ADGRL3 CA1 CNTN1 NPNT CPEB2 LRP12 KIF21A BRSK2 SALL4 SORBS1 SIN3A IRX3 REV3L TRIM67 SHANK2 CPEB4 PCDH7 SCAI | 7.14e-06 | 1106 | 234 | 26 | M39071 |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 1.44e-05 | 59 | 234 | 6 | M47989 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | ERBB4 SPOCK1 LPCAT4 CLASP2 BCL11A NRXN1 ATP11C CA1 CNTN1 NPNT FOXP2 KIF21A REV3L ZNF3 TRIM67 SHANK2 CPEB4 | 2.21e-05 | 584 | 234 | 17 | M39068 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 2.24e-05 | 169 | 234 | 9 | M39230 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 2.25e-05 | 212 | 234 | 10 | M39221 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.77e-05 | 40 | 234 | 5 | M5887 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | CFH PCSK5 HIP1 CARHSP1 AGPAT3 HMGCS1 MDH1 ERBIN MAP3K1 PIGR MTUS1 PKHD1 C3 QKI CNN2 NPNT PDCD6IP RNF213 LBR SLC3A1 IGF2R BAZ1A TJP1 KIAA1217 ARHGAP12 FBLIM1 TNS1 | 3.05e-05 | 1276 | 234 | 27 | M39173 |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 3.59e-05 | 224 | 234 | 10 | M9893 | |
| Coexpression | NABA_MATRISOME | PCSK5 GLDN SPOCK1 MMP21 LAMC3 COL22A1 ST14 MEP1A FNDC7 PXDN GPC4 ADAMTS20 NPNT GPC1 HSPG2 NID2 COL6A3 PLOD3 ABI3BP MUC5B THBS3 TNXB HCFC1 | 3.94e-05 | 1008 | 234 | 23 | MM17056 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 3.97e-05 | 43 | 234 | 5 | MM3857 | |
| Coexpression | PILON_KLF1_TARGETS_UP | CHAC2 CLASP2 HMGCS1 PXDN DDHD2 CA1 NID2 FLT1 FOXP2 SLC25A4 SIN3A C2CD3 SLC44A1 CPEB4 SCAI | 5.15e-05 | 503 | 234 | 15 | M2226 |
| Coexpression | NABA_MATRISOME | PCSK5 GLDN SPOCK1 MMP21 LAMC3 COL22A1 ST14 MEP1A FNDC7 PXDN GPC4 ADAMTS20 NPNT GPC1 HSPG2 NID2 COL6A3 PLOD3 ABI3BP MUC5B THBS3 TNXB HCFC1 | 5.15e-05 | 1026 | 234 | 23 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.83e-05 | 191 | 234 | 9 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.11e-05 | 196 | 234 | 9 | M3008 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP | 7.11e-05 | 196 | 234 | 9 | M8858 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP | 7.99e-05 | 199 | 234 | 9 | M6443 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP | 8.30e-05 | 200 | 234 | 9 | M7917 | |
| Coexpression | GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN | HMGCS1 ACTL6A SLC35E2B MAP3K1 COPS5 RWDD4 SLC25A4 DIDO1 RAPGEF2 | 8.30e-05 | 200 | 234 | 9 | M3074 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP2 SEPTIN9 CLASP2 PTPRA UBE3A DENND5A QKI REV3L C2CD3 BAZ1A ARHGAP12 ITSN2 RBM6 RAPGEF2 | 8.48e-05 | 466 | 234 | 14 | M13522 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | HIVEP2 LPCAT4 FAT2 MTUS1 QKI DIDO1 REV3L BAZ1A TAF5L RAPGEF2 USP6NL | 8.76e-05 | 300 | 234 | 11 | M8702 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP2 SEPTIN9 CLASP2 PTPRA UBE3A USP7 DENND5A QKI NIPBL DDX17 REV3L UST MSH6 C2CD3 IGF2R BAZ1A ARHGAP12 ITSN2 RBM6 RAPGEF2 | 9.29e-05 | 856 | 234 | 20 | M4500 |
| Coexpression | PILON_KLF1_TARGETS_UP | CHAC2 CLASP2 HMGCS1 PXDN DDHD2 CA1 NID2 FLT1 FOXP2 SLC25A4 SIN3A C2CD3 SLC44A1 CPEB4 SCAI | 1.16e-04 | 541 | 234 | 15 | MM1061 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP | 1.49e-04 | 127 | 234 | 7 | M40905 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | HMGCS1 PTPRA NF1 PTPRJ DIO2 CHD6 NMT1 FLT1 APMAP LBR PDLIM4 CDK7 | 1.68e-04 | 379 | 234 | 12 | M1885 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | VPS11 HIVEP2 VPS13C SEPTIN9 TNRC6B PTPN22 ARHGAP30 KPNA6 ERBIN PARP1 PTPRA PTPRJ UBE3A QKI NIPBL CNN2 DDX17 APMAP HECTD4 AKNA RNF213 SIN3A LBR REV3L GIMAP8 BAZ1A ITSN2 HECA | 1.70e-04 | 1492 | 234 | 28 | M40023 |
| Coexpression | VECCHI_GASTRIC_CANCER_EARLY_DN | CFH BCHE ERBIN ALDH1L2 CNN1 ADGRL3 CNTN1 IRX3 ACE2 MCTP1 IGHM PCDH7 | 1.81e-04 | 382 | 234 | 12 | M15472 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | HIVEP2 DIO2 QKI CNN2 CPEB2 PRICKLE1 SALL4 USP2 KIAA1217 ARHGAP12 CPEB4 ITSN2 RAPGEF2 FBLIM1 | 1.91e-04 | 504 | 234 | 14 | M2157 |
| Coexpression | HAY_BONE_MARROW_STROMAL | CFH GLDN NRXN1 HOXD11 GPC4 CNTN1 NPNT PLIN4 HSPG2 NID2 COL6A3 ABI3BP PCDHGA2 IRX3 PDLIM4 NPB TJP1 KIAA1217 | 1.98e-04 | 767 | 234 | 18 | M39209 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.07e-04 | 33 | 234 | 4 | MM477 | |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_DN | AGPAT3 BCL11A MBD4 PCDHGA10 COX15 KIAA1217 CPEB4 RAPGEF2 TM2D1 | 2.16e-04 | 227 | 234 | 9 | M18441 |
| Coexpression | DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS | 2.38e-04 | 97 | 234 | 6 | M40301 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | SPOCK1 ADGRB3 BCHE CLASP2 BCL11A UBE3A ALDH1L2 USP7 DIO2 ADAMTS20 ATP11C POFUT2 RWDD4 ADGRL3 CNTN1 CPEB2 DDX17 SGIP1 PDCD6IP FOXP2 KIF21A BRSK2 SALL4 REV3L | 1.16e-05 | 818 | 232 | 24 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | CFH PCSK5 TET2 ERBB4 GLDN MYO9A SEPTIN9 PXDN GPC4 CACNA1H CNN2 ADGRL3 PGBD5 COL6A3 SLC27A6 RNF213 REV3L ACE2 KIAA1217 FBLIM1 TNS1 CDK7 | 3.90e-05 | 768 | 232 | 22 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | CFH TET2 ERBB4 MYO9A SEPTIN9 HMGCS1 PXDN HOXD11 GPC4 CACNA1H CNN1 CNN2 ADGRL3 PGBD5 COL6A3 SLC27A6 RNF213 REV3L ACE2 IGF2R KIAA1217 FBLIM1 | 4.30e-05 | 773 | 232 | 22 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 COL22A1 NRXN1 PTPRQ PKHD1 ADAMTS20 SDK1 ADGRL3 CNTN1 SALL4 MUC5B XIRP2 | 3.56e-10 | 184 | 238 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 COL22A1 NRXN1 PTPRQ PKHD1 ADAMTS20 SDK1 ADGRL3 CNTN1 SALL4 MUC5B XIRP2 | 3.56e-10 | 184 | 238 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 COL22A1 NRXN1 PTPRQ PKHD1 ADAMTS20 SDK1 ADGRL3 CNTN1 SALL4 MUC5B XIRP2 | 3.56e-10 | 184 | 238 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CFH IGFN1 C3 ADGRL3 CNTN1 NID2 COL6A3 ABI3BP PRICKLE1 UST PCDH7 TNXB | 6.53e-10 | 194 | 238 | 12 | c49f72441b3557e2c3a9c4239e68c0cf0652814b |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | CFH LPCAT4 PARP1 MTUS1 CHD6 SDK1 NPNT GPC1 KIF21A KIAA1217 GALNT5 PCDH7 | 7.78e-10 | 197 | 238 | 12 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | CFH LPCAT4 PARP1 MTUS1 CHD6 SDK1 NPNT GPC1 KIF21A KIAA1217 GALNT5 PCDH7 | 7.78e-10 | 197 | 238 | 12 | 80b05c8ad9c1edc5dea3236079372475431343fe |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYO9A SH3RF2 PTPRQ PKHD1 C3 NPNT NID2 KIF21A SALL4 IRX3 SHANK2 GALNT5 | 9.25e-10 | 200 | 238 | 12 | ddfb1f006365bf16203ee49f20200f68220cc288 |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | SPOCK1 ADGRB3 PXDN DIO2 ADGRL3 HSPG2 NID2 COL6A3 FLT1 ABI3BP TNXB | 4.35e-09 | 182 | 238 | 11 | fbd5e332df73bf7141c822fa67b76367dc962017 |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MTUS1 SH3RF2 PKHD1 C3 NPNT HSPG2 FOXP2 KIF21A SHANK2 KIAA1217 GALNT5 | 4.88e-09 | 184 | 238 | 11 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ARHGAP32 ERN1 PIGR MTUS1 C3 NPNT FOXP2 KIF21A SHANK2 GALNT5 ACSL5 | 5.46e-09 | 186 | 238 | 11 | e83718fabb057100835d3357df407f283d23fe16 |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | CFH SPOCK1 ADGRB3 PXDN DIO2 ADGRL3 NID2 COL6A3 ABI3BP FOXP2 TNXB | 6.11e-09 | 188 | 238 | 11 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | CFH PCSK5 HIVEP2 SPOCK1 C3 DENND5A SGIP1 ABI3BP FOXP2 STEAP4 REV3L | 8.03e-09 | 193 | 238 | 11 | 7426c291bac59e539c427bcaae18abc7d397d44e |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | CFH PCSK5 HIVEP2 SPOCK1 PXDN C3 SDK1 SGIP1 ABI3BP FOXP2 STEAP4 | 8.47e-09 | 194 | 238 | 11 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | CFH SPOCK1 ADGRB3 PXDN C3 ADGRL3 COL6A3 ABI3BP FOXP2 UST TNXB | 8.93e-09 | 195 | 238 | 11 | f423baa36ac7cdc383c033e35a7d17e6bf913323 |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | CFH ARHGAP32 SPOCK1 ADGRB3 C3 ADGRL3 COL6A3 ABI3BP FOXP2 REV3L UST | 8.93e-09 | 195 | 238 | 11 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | CFH PCSK5 SPOCK1 ADGRB3 PXDN C3 COL6A3 ABI3BP FOXP2 UST TNXB | 8.93e-09 | 195 | 238 | 11 | a78b605b49acd8c9d68716266ca269dafcd910b9 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CFH BCHE PXDN DIO2 ADGRL3 CNTN1 GPC1 COL6A3 STEAP4 PCDH7 TNXB | 1.05e-08 | 198 | 238 | 11 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ARHGAP32 ERN1 PIGR MTUS1 C3 FOXP2 KIF21A STEAP4 IRX3 GALNT5 ACSL5 | 1.05e-08 | 198 | 238 | 11 | 285f729140b1df029c24f6ca1d2438470ac51794 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP32 ERBB4 ADGRB3 TNRC6B CLASP2 NF1 PTPRJ FOXP2 SHANK2 RBM6 RAPGEF2 | 1.10e-08 | 199 | 238 | 11 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | CFH LAMC3 PXDN HOXD11 NID2 COL6A3 SGIP1 SLC27A6 STEAP4 REV3L FBLIM1 | 1.10e-08 | 199 | 238 | 11 | 9503646ff1ad248181146ce767e9d12e882ec3bd |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | CFH ARHGAP32 ADGRB3 ALDH1L1 PIGR SH3RF2 ALDH1L2 FOXP2 KIF21A MUC5B KIAA1217 | 1.16e-08 | 200 | 238 | 11 | 682960e28542a3d6c119047cd0131941932cfdea |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.94e-08 | 180 | 238 | 10 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | SPOCK1 ADGRB3 PXDN DIO2 ADGRL3 COL6A3 ABI3BP FOXP2 PRICKLE1 TNXB | 6.39e-08 | 185 | 238 | 10 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.07e-08 | 187 | 238 | 10 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | LAMC3 HOXD11 SDK1 CNTN1 COL6A3 SGIP1 SLC27A6 SORBS1 REV3L TNS1 | 7.07e-08 | 187 | 238 | 10 | 76bfe8c42430a230a8bdf299575c444fb7780f24 |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.07e-08 | 187 | 238 | 10 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.44e-08 | 188 | 238 | 10 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | GPC4 PKHD1 SDK1 ABI3BP FOXP2 PRICKLE1 KIF21A SLC3A1 IQCA1 TNS1 | 7.82e-08 | 189 | 238 | 10 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.21e-08 | 190 | 238 | 10 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | LAMC3 PXDN HOXD11 CNN1 CNTN1 NID2 COL6A3 PRICKLE1 SORBS1 PCDH7 | 8.63e-08 | 191 | 238 | 10 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.63e-08 | 191 | 238 | 10 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | LAMC3 PXDN HOXD11 CNN1 CNTN1 NID2 COL6A3 PRICKLE1 SORBS1 PCDH7 | 8.63e-08 | 191 | 238 | 10 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CFH LAMC3 CNTN1 NID2 COL6A3 ABI3BP KIAA1217 FBLIM1 PCDH7 TNXB | 9.06e-08 | 192 | 238 | 10 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CFH LAMC3 CNTN1 NID2 COL6A3 SORBS1 KIAA1217 FBLIM1 PCDH7 TNXB | 9.06e-08 | 192 | 238 | 10 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.06e-08 | 192 | 238 | 10 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | GABRP ERBB4 MYO9A MAP3K1 PTPRJ GPC4 PKHD1 ABI3BP FOXP2 RNF213 | 9.98e-08 | 194 | 238 | 10 | e577d9e88390b36b5a09b97fe1026089892275a3 |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.98e-08 | 194 | 238 | 10 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 9.98e-08 | 194 | 238 | 10 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CFH LAMC3 PXDN CNTN1 COL6A3 STEAP4 SORBS1 KIAA1217 FBLIM1 TNXB | 9.98e-08 | 194 | 238 | 10 | cf0244a29934e515446ac917d3c30672b460fb04 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CFH LAMC3 PXDN CNTN1 COL6A3 STEAP4 SORBS1 KIAA1217 FBLIM1 TNXB | 9.98e-08 | 194 | 238 | 10 | ba7f971fb9a19423602da60770f23d9fead4a451 |
| ToppCell | lung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass | 1.02e-07 | 147 | 238 | 9 | 8a3039de45b8087f8319e2e37329acf7278219b7 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | ERBB4 PIGR MTUS1 NPNT FOXP2 STEAP4 IRX3 SHANK2 TJP1 KIAA1217 | 1.05e-07 | 195 | 238 | 10 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | SPOCK1 LAMC3 HOXD11 SDK1 CNTN1 NID2 COL6A3 SGIP1 SORBS1 REV3L | 1.05e-07 | 195 | 238 | 10 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | ERBB4 PIGR MTUS1 NPNT FOXP2 STEAP4 IRX3 SHANK2 TJP1 KIAA1217 | 1.05e-07 | 195 | 238 | 10 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | CCDC190 EHD2 PXDN ALDH1L2 HSPG2 COL6A3 ABI3BP KIAA1217 GALNT5 TNS1 | 1.05e-07 | 195 | 238 | 10 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-07 | 195 | 238 | 10 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | LAMC3 HOXD11 CNN1 ADGRL3 COL6A3 SGIP1 SORBS1 FBLIM1 PCDH7 TNXB | 1.10e-07 | 196 | 238 | 10 | fa445f4240c521cf04eb2e2f79a5c55fda31209a |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | LAMC3 HOXD11 CNN1 ADGRL3 COL6A3 SGIP1 SORBS1 FBLIM1 PCDH7 TNXB | 1.10e-07 | 196 | 238 | 10 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CFH ADGRB3 CACNA1H SDK1 ADGRL3 COL6A3 SGIP1 STEAP4 SORBS1 FBLIM1 | 1.15e-07 | 197 | 238 | 10 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.15e-07 | 197 | 238 | 10 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.15e-07 | 197 | 238 | 10 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | ARHGAP32 MTUS1 C3 NPNT FOXP2 KIF21A STEAP4 IRX3 GALNT5 ACSL5 | 1.15e-07 | 197 | 238 | 10 | 44a59dfb889577b3160a5b13ada1276771a00241 |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.15e-07 | 197 | 238 | 10 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-07 | 197 | 238 | 10 | 94a7270ea6d4b586f58875c9e4071ce0f683ef7e | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | CFH GABRP ARHGAP32 ST14 PIGR MTUS1 KIF21A STEAP4 TJP1 KIAA1217 | 1.21e-07 | 198 | 238 | 10 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SH3RF2 PTPRQ PKHD1 ALPI NPNT HSPG2 NID2 KIF21A SHANK2 GALNT5 | 1.21e-07 | 198 | 238 | 10 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.21e-07 | 198 | 238 | 10 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-07 | 198 | 238 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.21e-07 | 198 | 238 | 10 | c4e7512f0e1d115f2be8acae6048eda8b6b640b2 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | PCSK5 ADGRB3 LAMC3 SDK1 NID2 COL6A3 SGIP1 ABI3BP STEAP4 TNXB | 1.21e-07 | 198 | 238 | 10 | bd11b0e9e80449aab979a02c1023e0638c431c7c |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ERBB4 PIGR MTUS1 NPNT FOXP2 STEAP4 MUC5B IRX3 SHANK2 KIAA1217 | 1.21e-07 | 198 | 238 | 10 | 6ba5e5970109a04ed968bac7ff099ae250c579dc |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.27e-07 | 199 | 238 | 10 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | VPS13C SH3RF2 PTPRQ PKHD1 ALPI NPNT KIF21A SALL4 SHANK2 GALNT5 | 1.27e-07 | 199 | 238 | 10 | a270630626df614f8605abddb7dee7c4d74f6149 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.33e-07 | 200 | 238 | 10 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.33e-07 | 200 | 238 | 10 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.33e-07 | 200 | 238 | 10 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-07 | 158 | 238 | 9 | 1cefb82b9bf79c687a119be568cfc15b14c6e040 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.21e-07 | 161 | 238 | 9 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.21e-07 | 161 | 238 | 9 | 048b7dc00746987a24bf870d4d278c4183eb04a2 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.07e-07 | 173 | 238 | 9 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYO9A TNRC6B MTUS1 NPNT SLC44A1 SHANK2 KIAA1217 GALNT5 PCDH7 | 4.93e-07 | 177 | 238 | 9 | b7fee75de7e96924af488a5baa2334711889ae7c |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.95e-07 | 181 | 238 | 9 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-07 | 181 | 238 | 9 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.23e-07 | 182 | 238 | 9 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.52e-07 | 183 | 238 | 9 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.82e-07 | 184 | 238 | 9 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.82e-07 | 184 | 238 | 9 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 6.82e-07 | 184 | 238 | 9 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.82e-07 | 184 | 238 | 9 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.14e-07 | 185 | 238 | 9 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.14e-07 | 185 | 238 | 9 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-07 | 186 | 238 | 9 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 7.47e-07 | 186 | 238 | 9 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.47e-07 | 186 | 238 | 9 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-07 | 187 | 238 | 9 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-07 | 187 | 238 | 9 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.17e-07 | 188 | 238 | 9 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 8.17e-07 | 188 | 238 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.17e-07 | 188 | 238 | 9 | 6164d467b612767ceba15de34176bcc8e8c36ab8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.17e-07 | 188 | 238 | 9 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.17e-07 | 188 | 238 | 9 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.17e-07 | 188 | 238 | 9 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.17e-07 | 188 | 238 | 9 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.17e-07 | 188 | 238 | 9 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.54e-07 | 189 | 238 | 9 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 8.54e-07 | 189 | 238 | 9 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.54e-07 | 189 | 238 | 9 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-07 | 190 | 238 | 9 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 8.92e-07 | 190 | 238 | 9 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-07 | 191 | 238 | 9 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | ERN1 SEPTIN9 ALDH1L1 MAP3K1 ALMS1 CACNA1H CNTN1 HSPG2 LRP12 MUC5B ZNF3 NUP188 HCFC1 | 1.38e-07 | 196 | 235 | 13 | 4423_DN |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; HL60; HT_HG-U133A | SEPTIN9 ST14 NF1 PIGR GNRH2 PGBD5 ARAP1 FLT1 STEAP4 USP2 NUP188 HCFC1 | 1.04e-06 | 197 | 235 | 12 | 3045_UP |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A | PTPN22 EHD2 PTPRA C3 CACNA1H NMT1 CNN1 PGBD5 SIN3B MCTP1 GPATCH3 | 7.15e-06 | 198 | 235 | 11 | 1499_UP |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; MCF7; HT_HG-U133A | ALDH1L1 MAP3K1 NF1 UBE3A ACSBG2 CNN1 PGBD5 LRP12 BRSK2 STEAP4 THBS3 | 7.15e-06 | 198 | 235 | 11 | 6106_UP |
| Disease | v-set and transmembrane domain-containing protein 4 measurement | 9.19e-06 | 6 | 230 | 3 | EFO_0803247 | |
| Disease | mean arterial pressure | SEPTIN9 PTPRJ PKHD1 USP7 NMT1 NPNT SGIP1 HECTD4 RNF213 THBS3 UTP25 KIAA1217 CPEB4 ZBTB10 TNS1 | 9.93e-06 | 499 | 230 | 15 | EFO_0006340 |
| Disease | Malignant neoplasm of breast | MAGEA4 GABRP ERBB4 MRPL19 BCHE BCL11A MAP3K1 PARP1 HOXB9 NF1 HOXD11 NIPBL GPC1 NID2 FLT1 KIF6 SORBS1 MSH6 THBS3 DAW1 ITSN2 GALNT5 TNS1 | 1.28e-05 | 1074 | 230 | 23 | C0006142 |
| Disease | coronary artery disease | TET2 VPS11 ERBB4 HIVEP2 MAP3K1 PARP1 NRXN1 PTPRJ PKHD1 PLCG2 DENND5A ADGRL3 COL6A3 FLT1 SLC27A6 HECTD4 CENPO RNF213 IGF2R KIAA1217 RAPGEF2 TNS1 TNXB HECA | 2.31e-05 | 1194 | 230 | 24 | EFO_0001645 |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 2.54e-05 | 8 | 230 | 3 | EFO_0801373 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.70e-05 | 152 | 230 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Craniofacial Abnormalities | 3.25e-05 | 156 | 230 | 8 | C0376634 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 3.79e-05 | 9 | 230 | 3 | EFO_0010613 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 5.39e-05 | 10 | 230 | 3 | EFO_0801535 | |
| Disease | OCIA domain-containing protein 1 measurement | 5.39e-05 | 10 | 230 | 3 | EFO_0008252 | |
| Disease | Intellectual Disability | HIVEP2 ACTL6A BCL11A PARP1 AP2M1 ADPRS NF1 NRXN1 QKI BRSK2 SIN3A ACE2 SHANK2 | 5.47e-05 | 447 | 230 | 13 | C3714756 |
| Disease | Apraxia, Motor | 6.05e-05 | 2 | 230 | 2 | C0234527 | |
| Disease | Dressing Apraxia | 6.05e-05 | 2 | 230 | 2 | C0234529 | |
| Disease | Ideational Apraxia | 6.05e-05 | 2 | 230 | 2 | C0234526 | |
| Disease | Apraxia, Oral | 6.05e-05 | 2 | 230 | 2 | C0454608 | |
| Disease | cytokine receptor common subunit beta measurement | 6.05e-05 | 2 | 230 | 2 | EFO_0801518 | |
| Disease | nuclear pore membrane glycoprotein 210-like measurement | 6.05e-05 | 2 | 230 | 2 | EFO_0802821 | |
| Disease | complement C3B measurement | 6.05e-05 | 2 | 230 | 2 | EFO_0020275 | |
| Disease | synaptic vesicle glycoprotein 2A measurement | 6.05e-05 | 2 | 230 | 2 | EFO_0803115 | |
| Disease | Apraxia, Gestural | 6.05e-05 | 2 | 230 | 2 | C0422892 | |
| Disease | Apraxia, Facial-Oral | 6.05e-05 | 2 | 230 | 2 | C0750928 | |
| Disease | Apraxia, Developmental Verbal | 6.05e-05 | 2 | 230 | 2 | C0750927 | |
| Disease | Apraxia, Articulatory | 6.05e-05 | 2 | 230 | 2 | C3495144 | |
| Disease | progonadoliberin-2 measurement | 6.05e-05 | 2 | 230 | 2 | EFO_0801925 | |
| Disease | Apraxias | 6.05e-05 | 2 | 230 | 2 | C0003635 | |
| Disease | Apraxia, Verbal | 6.05e-05 | 2 | 230 | 2 | C0349391 | |
| Disease | Semantic-Pragmatic Disorder | 7.36e-05 | 11 | 230 | 3 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 7.36e-05 | 11 | 230 | 3 | C0751257 | |
| Disease | Language Delay | 7.36e-05 | 11 | 230 | 3 | C0023012 | |
| Disease | Language Development Disorders | 7.36e-05 | 11 | 230 | 3 | C0023014 | |
| Disease | Speech Delay | 7.36e-05 | 11 | 230 | 3 | C0241210 | |
| Disease | oncostatin-M measurement | 9.76e-05 | 12 | 230 | 3 | EFO_0010792 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 9.76e-05 | 12 | 230 | 3 | EFO_0020833 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.68e-04 | 148 | 230 | 7 | C0279702 | |
| Disease | focal adhesion kinase 1 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0020393 | |
| Disease | versican core protein measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0803248 | |
| Disease | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0803220 | |
| Disease | U6 snRNA phosphodiesterase measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0803211 | |
| Disease | PDZ and LIM domain protein 4 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802849 | |
| Disease | phosphatidylinositol transfer protein alpha isoform measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802862 | |
| Disease | orexigenic neuropeptide QRFP measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802832 | |
| Disease | complement C3D fragment measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0020277 | |
| Disease | interleukin-17A measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0022026 | |
| Disease | thioredoxin domain-containing protein 11 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0803147 | |
| Disease | nectin-2 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802788 | |
| Disease | myelin regulatory factor measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802767 | |
| Disease | C-type lectin domain family 4 member M measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0020202 | |
| Disease | aurora kinase A measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0020168 | |
| Disease | complement C3 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0004983 | |
| Disease | rho guanine nucleotide exchange factor 7 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0803020 | |
| Disease | inactive dipeptidyl peptidase 10 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802624 | |
| Disease | DCC-interacting protein 13-alpha measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802455 | |
| Disease | g-protein coupled receptor 26 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802558 | |
| Disease | ES1 protein homolog, mitochondrial measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802529 | |
| Disease | breast carcinoma, hormone replacement therapy | 1.81e-04 | 3 | 230 | 2 | EFO_0000305, EFO_0003961 | |
| Disease | pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0801905 | |
| Disease | cyclin-dependent kinase 2-associated protein 1 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802440 | |
| Disease | roundabout homolog 3 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0020714 | |
| Disease | beta-defensin 107 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802317 | |
| Disease | Apraxia of Phonation | 1.81e-04 | 3 | 230 | 2 | C0264611 | |
| Disease | kinetochore protein NDC80 homolog measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0801748 | |
| Disease | glypican-2 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0020414 | |
| Disease | protein transport protein Sec61 subunit gamma measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802965 | |
| Disease | proteasome subunit beta type-5 measurement | 1.81e-04 | 3 | 230 | 2 | EFO_0802923 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | TET2 ERBB4 SPOCK1 BCL11A ALMS1 NRXN1 UBAP2L SDK1 ADGRL3 SGIP1 FOXP2 REV3L MSH6 MCTP1 CPEB4 PCDH7 SCAI | 2.00e-04 | 801 | 230 | 17 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Autistic Disorder | 2.24e-04 | 261 | 230 | 9 | C0004352 | |
| Disease | vision disorder | 2.43e-04 | 16 | 230 | 3 | MONDO_0021084 | |
| Disease | FEV/FEC ratio | PCSK5 TET2 HIVEP2 VPS13C PSMA4 BCHE BCL11A MAP3K1 MTUS1 DENND5A ARAP1 NPNT HSPG2 NID2 COL6A3 FLT1 THBS3 ARHGAP12 CPEB4 TNS1 TNXB HECA | 2.64e-04 | 1228 | 230 | 22 | EFO_0004713 |
| Disease | neuroimaging measurement | RGPD1 TNRC6B COL22A1 MAP3K1 NF1 PKHD1 ADAMTS20 KIF6 FOXP2 SLC27A6 BRSK2 REV3L BAZ1A ARHGAP12 CPEB4 RAPGEF2 TNS1 PCDH7 SCAI IPO11 | 2.91e-04 | 1069 | 230 | 20 | EFO_0004346 |
| Disease | risk-taking behaviour | TET2 BCL11A NF1 NRXN1 SDK1 ADGRL3 SGIP1 FOXP2 REV3L MSH6 THBS3 CPEB4 ZBTB10 PCDH7 TNXB IPO11 | 3.55e-04 | 764 | 230 | 16 | EFO_0008579 |
| Disease | dipeptidyl peptidase 1 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0020325 | |
| Disease | t-cell surface glycoprotein CD8 beta chain measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0803135 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0801374 | |
| Disease | magnesium transporter NIPA4 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0802723 | |
| Disease | casein kinase II subunit alpha measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0020238 | |
| Disease | ATP synthase subunit beta, mitochondrial measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0020166 | |
| Disease | sorting nexin-7 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0803094 | |
| Disease | rho-related GTP-binding protein Rho6 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0803022 | |
| Disease | keratin, type II cytoskeletal 7 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0802675 | |
| Disease | integrin alpha-5 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0802637 | |
| Disease | cold shock domain-containing protein C2 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0802415 | |
| Disease | receptor tyrosine-protein kinase erbb-4 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0020702 | |
| Disease | asthma, Hispanic or Latin American | 3.59e-04 | 4 | 230 | 2 | HANCESTRO_0014, MONDO_0004979 | |
| Disease | protein SERAC1 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0801963 | |
| Disease | zinc finger protein 18 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0802226 | |
| Disease | isochorismatase domain-containing protein 1 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0801735 | |
| Disease | protocadherin beta-1 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0802972 | |
| Disease | radiation-inducible immediate-early gene IEX-1 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0802987 | |
| Disease | histone acetyltransferase type b catalytic subunit measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0020452 | |
| Disease | body weight | PCSK5 TET2 LRRC66 ERBB4 HIVEP2 SPOCK1 VPS13C RGPD1 ADGRB3 TNRC6B NRXN1 PTPRJ QKI NIPBL ARAP1 NID2 FOXP2 NELFCD HECTD4 KIAA1217 CPEB4 PCDH7 | 3.80e-04 | 1261 | 230 | 22 | EFO_0004338 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.17e-04 | 45 | 230 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | mean platelet volume | TET2 LRRC66 ARHGAP32 HIVEP2 PTPRJ PI4KA USP7 PLCG2 CNN2 ARAP1 GP1BA NELFCD PCDHGA10 PCDHGA2 SORBS1 SIN3A CPEB4 ZBTB10 ACSL5 | 4.36e-04 | 1020 | 230 | 19 | EFO_0004584 |
| Disease | Renal Cell Carcinoma | 5.17e-04 | 128 | 230 | 6 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 5.17e-04 | 128 | 230 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 5.17e-04 | 128 | 230 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 5.17e-04 | 128 | 230 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 5.17e-04 | 128 | 230 | 6 | C1306837 | |
| Disease | COVID-19 (is_implicated_in) | 5.60e-04 | 21 | 230 | 3 | DOID:0080600 (is_implicated_in) | |
| Disease | zinc transporter 3 measurement | 5.96e-04 | 5 | 230 | 2 | EFO_0803287 | |
| Disease | dual specificity protein kinase CLK2 measurement | 5.96e-04 | 5 | 230 | 2 | EFO_0801548 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VNRFGTYPALASKNG | 61 | Q5FVE4 | |
| ISAGKVNLGAFRTYP | 176 | Q92905 | |
| GLQGANSFIFKYADP | 596 | Q15303 | |
| PGDKIIQANGYSFIN | 1371 | Q96RT1 | |
| NKYLDPNDFGAVRVG | 26 | Q86TW2 | |
| AFLVYGAPGFSKDNN | 356 | P06276 | |
| KRASYIPASDGVQNF | 631 | O60242 | |
| INTYNKTDVAAPFGG | 881 | Q3SY69 | |
| IFYNLAPADGKLSGS | 456 | Q9NZN4 | |
| NGYNCDFGAERLKIP | 291 | O96019 | |
| KYSLDFGPLDSRSGQ | 386 | Q9HAR2 | |
| GSSALGEKPITFYRQ | 1616 | Q8TCU4 | |
| KGYTQQLAFRQPSSA | 1051 | P01024 | |
| TYPKSKAGNAFIARG | 466 | Q6ZMI3 | |
| RAGPNGTLFVADAYK | 156 | Q9HDC9 | |
| NGFYPATRGNTAKCT | 296 | P08603 | |
| FPGSRGSVSSQLQYK | 4611 | Q96M86 | |
| LFNLSSSNIAGKYPG | 596 | Q86XH1 | |
| SRYDGNKQCELAFGP | 481 | P59510 | |
| FEYNPRNTSEAKAGT | 1506 | Q9NRL2 | |
| SPQQLAGKRIGVFSY | 361 | Q01581 | |
| NTTCPQGFEYKRVAG | 5566 | Q9HC84 | |
| PARGQGGAYAFLKFQ | 371 | Q8NDT2 | |
| SFYNITLTAKDGGNP | 416 | Q9Y5H1 | |
| ARGGNSLSDYKQVLG | 216 | Q9ULC6 | |
| QFLGNKVDSYGGSLR | 601 | P98160 | |
| NGTYRDANIKSPALA | 201 | Q96PU8 | |
| SIGDRSGIFPSNYVK | 1021 | Q9NZM3 | |
| SNSKPVNAAGRYFNS | 426 | Q9Y2R2 | |
| VNAAGRYFNSKVPIT | 431 | Q9Y2R2 | |
| GFRPEYSASQLKGFS | 171 | P09874 | |
| ILKPFGNSISRYNGE | 121 | Q14739 | |
| AEQYPEVGTGKRFLN | 151 | O60568 | |
| LQPGTAYKFRVAGIN | 1856 | P51610 | |
| ACENPQRKSFYGSGT | 251 | Q6PIW4 | |
| NDYKVASPALRAVGN | 306 | O60684 | |
| ENLAPVTTFGKTNGY | 1321 | Q12913 | |
| LGGKGPFSYNLQEVR | 241 | Q92813 | |
| GFRLAYFSGKSEEPN | 151 | Q9Y561 | |
| DSNGLSDPYVKFRLG | 486 | Q6DN14 | |
| SYDGLLGNNQIFPKT | 186 | P43358 | |
| AEGPNRLLYKDGFST | 421 | Q643R3 | |
| YNRGGLSPANDTGAK | 41 | P30419 | |
| LKRYFQAGGSPENVI | 66 | Q8IXH7 | |
| DPAGGQYLTVSAAKA | 446 | Q6UXI9 | |
| LAGGQPRFNDYKAND | 96 | A6NFK2 | |
| QEKAVGAAAYGARSP | 251 | Q9UBI9 | |
| KPAFQNGSSGSFYLK | 831 | Q9ULD2 | |
| NGSSGSFYLKPLVSR | 836 | Q9ULD2 | |
| RQIYGAKGFSLSDVP | 36 | P35052 | |
| KADSAGVRPGAQAYL | 526 | O75487 | |
| YAKVSGGPSLEQRFE | 141 | Q9Y262 | |
| KAGQSPLGDIFNYTT | 356 | Q5VTL7 | |
| VQGLGADSKNLYPFL | 631 | Q9UI26 | |
| GVQLGKRYNGSDPAS | 441 | Q9H252 | |
| RAEYKATGGPAVFQK | 571 | Q8IWQ3 | |
| AGYAASRQLKDPFLS | 661 | Q9H165 | |
| SSYLGNGFQKRPEDV | 71 | Q86UF4 | |
| PGSNAVFYTTNFGEK | 61 | Q5CZC0 | |
| FKYRGQDGTHASPKN | 321 | Q5CZC0 | |
| LYSIGNGSVFGKDQP | 21 | P40925 | |
| LQFPKTGSSRRYGNV | 221 | Q96I76 | |
| GFPEANRIASKYGFI | 46 | Q92824 | |
| SNELYKPLRAEGTNF | 481 | Q8WUM4 | |
| PYSFRITKGNNGSAF | 3461 | Q9NYQ8 | |
| GYPDGGAAQAFSKRT | 161 | Q8N119 | |
| GANGEVTYSFRKLPD | 276 | Q9Y5H3 | |
| NADLNYSIVGGNPFK | 776 | O60245 | |
| KNIPTSLGYGAALNA | 596 | O15409 | |
| DNKAEFPSYLLGGRS | 936 | Q6KC79 | |
| AFNNPYGDKIATGSF | 141 | Q8N136 | |
| YTLFLQRNPDFKGGV | 331 | O94830 | |
| GSLSGPAKDFYQREF | 1721 | P42356 | |
| NTGSLSGPAKDFYQR | 186 | Q8N8J0 | |
| NIAKPVAGSVLAGYN | 76 | Q6ZMV9 | |
| LDFGYPQNSETGALK | 116 | Q96CW1 | |
| RNGDTASPKEYTAGR | 106 | P07237 | |
| GFRSVPLKNGYSEDI | 1161 | P16885 | |
| SSKGPETLFAGYNLN | 791 | Q9ULB1 | |
| FGPRSLQKYDSGSFA | 226 | Q96A73 | |
| SGSFATQAYRGAQKP | 236 | Q96A73 | |
| RGISYFGTLKFSDPN | 341 | Q6IE36 | |
| YAGPNTNSRKVAEYG | 681 | Q9Y4D8 | |
| KSYGFNAARLANLPE | 1296 | P52701 | |
| PQSRTYATALGQGAF | 2056 | A7KAX9 | |
| EGSFARQQSLYAPKG | 281 | O95402 | |
| SKSPGLDNAYSNEGF | 411 | Q68CR7 | |
| TGLIRDANQNFGPSY | 126 | Q8IWW6 | |
| NISVYAVNSAGAGPK | 1761 | Q9UMZ3 | |
| AKFPSGQYASSRQPG | 26 | P17482 | |
| YPADASQNGIRLDGK | 236 | P09923 | |
| ATLPFRLNGFGNSYT | 406 | Q9Y5I4 | |
| DFTRPNGTDDKSIYG | 66 | A0A075B767 | |
| ANGLQFLGTRPKESY | 201 | Q14112 | |
| LNYKFPGLSGNADDT | 356 | Q96MT3 | |
| RNAAGKNYIIFTGPS | 331 | Q8N414 | |
| GPLYKNGSLRNADSE | 761 | A6NKT7 | |
| FQGRFELSGKSRQYP | 26 | P0CF75 | |
| EKQASSFDFNGPYLG | 581 | P32927 | |
| RYNPAALTNKGNTVF | 481 | Q13099 | |
| VYPLFGRNASNLSGA | 1536 | Q4AC94 | |
| PKGAGRVAFSNQQSY | 481 | Q7Z5Q1 | |
| FPSVLRGGKYAATSQ | 56 | P01871 | |
| IPQYNFINKSRLGSG | 81 | Q96LM5 | |
| DPNDGSLYTLGSKNN | 76 | O75460 | |
| YRDAQGNPLSGVFKF | 556 | Q8TD26 | |
| NRSVLKGGPFSDSYR | 76 | P00915 | |
| FGLAKSFGSPNRAYT | 156 | P50613 | |
| GFRVQPDQGKIFYSS | 56 | Q7Z7M9 | |
| KTNNVLQPGESYLFG | 1761 | O75417 | |
| GSANVGKTNFPYVRD | 646 | P12111 | |
| AFNNKGDGPYSLVAV | 786 | Q12860 | |
| NGGPYHVNFKTEGSR | 196 | Q8ND71 | |
| ASNFYSAVGRNGILP | 161 | P31277 | |
| PGFASQDKALGSAQY | 1686 | Q9BTC0 | |
| YASIDISKGENNPGF | 781 | Q9BYF1 | |
| RSSSNAPKYGRGQLN | 341 | Q7Z591 | |
| GYKSSPDQFVGIFAQ | 126 | Q9ULC5 | |
| FEPARAQFNGKGSYG | 136 | Q9NX46 | |
| AYFASLAARPGNVKG | 1611 | Q8NFW1 | |
| YIQASKARDGASPFI | 41 | Q6IQ26 | |
| DKRNGNIAGSPLHSY | 446 | Q6IQ26 | |
| GRGQFSGRTYNPTAK | 581 | P20794 | |
| KTAGRFDVYFISPQG | 101 | O95243 | |
| QENSLYTIPKGFFGS | 196 | P07359 | |
| RQLAGQSFYQKDGRP | 216 | Q8WUP2 | |
| PGRLQDFYDSTAGKF | 161 | Q7Z4H3 | |
| FAIDTKYNDGSPGRE | 601 | Q8WWI5 | |
| NLLSFTYKLDPGGQS | 216 | Q9BU64 | |
| PKGAGRVAFSNQQSY | 621 | Q17RY0 | |
| FKNDRSLEGNPAVYS | 1191 | Q86VF2 | |
| GTAYTFFTPGNLKQA | 516 | Q92841 | |
| VAGLDAGLVYNSFPK | 281 | Q7KZN9 | |
| YEEGFDGSNPQKKQR | 236 | Q96EB1 | |
| YPGGKRALSSAQDPQ | 31 | O43555 | |
| YSVDAQGFLDKPGRA | 2136 | O95180 | |
| ATLQFRPGYDGKTSI | 1086 | Q7Z5N4 | |
| QDKVAAGNGIPYALS | 446 | Q9UJQ4 | |
| DIKQAYTQFGGKRPF | 116 | P25789 | |
| LSLPGFENLTAGYNK | 36 | O00591 | |
| GYRQKDSYIASQGPL | 596 | P18433 | |
| GPLYKNGSLRNADSE | 751 | P0DJD0 | |
| SYAFETQANPGKGEG | 1086 | Q7Z6I6 | |
| GQYQFGDPSRPKNAT | 121 | P78415 | |
| NFNNLPGVYDSSGIR | 311 | A6NHM9 | |
| NPFIYSLRNGDVKGG | 286 | Q15612 | |
| SFLIGGDSPDNKYRV | 326 | Q13233 | |
| AYVPVSRAVSQKFGG | 221 | P49247 | |
| NPINGKSFSLGDIYF | 2141 | P11717 | |
| GPKVLSAEQGSYFVR | 1166 | Q96Q06 | |
| SEASKPRAQAGSGYN | 181 | Q5QGT7 | |
| PNYIKRFASGGCDNL | 176 | P55735 | |
| FSPNGKYLASAGEDQ | 476 | O75529 | |
| GFNVDTLPAYAKRSQ | 101 | Q7Z7C8 | |
| VSNKKRFQGEYGSDP | 386 | Q68CQ4 | |
| YGQSKSFPEGKTARD | 421 | P78332 | |
| GYRNKSTFSVNRGPD | 151 | Q96GJ1 | |
| TQPNTFGLFLYKEQG | 666 | Q13671 | |
| IPYFQARLAGAGNST | 36 | Q14542 | |
| GLDPKTTYNRFCGDQ | 401 | Q9Y2G5 | |
| SEGGPLYKNGSLRNA | 756 | P0DJD1 | |
| VAAEPKQSGSFRYLQ | 201 | P50479 | |
| FGPYEGQISTQDKSA | 176 | Q9NQV5 | |
| SGRGTASPKEFYAKN | 851 | O00291 | |
| FRYLFQGTKGDPQNS | 401 | Q16819 | |
| ASRNEKAPVDFGYVG | 266 | Q9UHD8 | |
| RNYSQETVPKASFGF | 1256 | Q5T5P2 | |
| NAKEAGGNYTPALTE | 341 | Q96ST3 | |
| VKIRFGSDPATYNGF | 51 | O75182 | |
| IYPRSFKDSNKDGNG | 126 | Q07837 | |
| NSRPAQGSYFGNKRA | 76 | O15457 | |
| EDKPFQGRAQITLYG | 2001 | P08F94 | |
| SGNETKTYPAFERGQ | 1301 | P14410 | |
| FAGRPSKGAQLEDYF | 891 | Q9BVR0 | |
| IAGSKLSPRLQYFGQ | 571 | P11215 | |
| PDGRGTYQCKANVFL | 101 | Q8NG41 | |
| SKEPGVQAYIGNRLF | 151 | Q9UBF8 | |
| NTGSLSGPAKDFYQR | 186 | A4QPH2 | |
| KDVLNYGLFQPASNG | 96 | Q9UPX8 | |
| YGLFQPASNGRDGKF | 101 | Q9UPX8 | |
| NTYNKTDVAAPFGGF | 861 | O75891 | |
| KSDGLRGLYQGFNVS | 166 | P12235 | |
| GPTLFQTDGQDYKAG | 1111 | Q96P48 | |
| IFNAAGPSGRNTEYL | 131 | Q8WUX2 | |
| FSATVRASQGPVYKG | 51 | Q9Y2V2 | |
| NLYIKRAQTGSGGAD | 1271 | O75122 | |
| FNRGPAYGLSAEVKN | 6 | P51911 | |
| FNKGPSYGLSAEVKN | 6 | Q99439 | |
| GRQAARNSDYSVPKF | 841 | Q8NB49 | |
| TADPYASGKISQFLG | 121 | P49406 | |
| PVGGTYDLSGDFQKQ | 1996 | A4UGR9 | |
| RKGYTLAPSGTVDNF | 1126 | Q9Y4G8 | |
| QSALYKLAASSGGPA | 91 | Q8IZ63 | |
| GSGFPKDQEYTQLCR | 3071 | Q63HN8 | |
| FPSQVVYNRVGKCGS | 101 | Q9Y2C2 | |
| DGRPYAGAVQKFLAS | 231 | P49842 | |
| YNARVKAFNSSGVGP | 581 | Q6ZTA4 | |
| ASRGNLPKYSAFQLA | 756 | Q92738 | |
| NYPVTGLAFRQAGKT | 186 | Q9H270 | |
| PRGERSEKYNDFGNS | 166 | P17036 | |
| GASSAYLENSKGAPN | 91 | Q05086 | |
| NPYSGDLTKFGRGDA | 856 | Q14157 | |
| YDVTLNFRGNKNPSL | 226 | Q9NRZ7 | |
| QIDGPSLNNTYGFKV | 2266 | O60673 | |
| SFQYRIGENGDPKAF | 31 | Q6NW29 | |
| FAVGTKNYSVSAGDP | 496 | A6NJ88 | |
| PTGTFLYAASGNAVR | 1461 | Q7Z4S6 | |
| VSKKSNGAPNGFYAE | 56 | Q9BQI5 | |
| GGRLRKAQGTFNSPY | 341 | Q9Y5Y6 | |
| NGNAQPSSLAAKGYR | 121 | Q9BX66 | |
| FKVSYQLADGGEPQS | 3786 | P22105 | |
| DRAGSLPNYATINGK | 1396 | Q9HBL0 | |
| LLKSVYENGFNTPRG | 766 | Q92626 | |
| AANFIKGTIQAAPYG | 91 | Q6ICG8 | |
| YGNELAGSRKQGAVS | 361 | Q08629 | |
| GFFKPISCRNVNGYS | 106 | Q9BX74 | |
| QTEGGRTGPYKAVAF | 91 | O75631 | |
| SIFYQAGTSKAGNPI | 1591 | P21359 | |
| YLQNKNGDGLPSAVA | 1501 | Q5SRE5 | |
| YPKALQDQSQRGSLF | 461 | Q8N9R8 | |
| CGYSVVFGSRNPQKT | 41 | Q687X5 | |
| EGSSKPFFYNRQDNG | 2926 | Q709C8 | |
| PVIGRSGKSFSYNQD | 281 | P0CK96 | |
| SKYAGRANLTNFPEN | 76 | P01833 | |
| YRLSKNEAPEGNLGD | 221 | Q9UKN8 | |
| PKQGGVLFGLYSRQD | 66 | P49746 | |
| GSGVYRQAGPSSDQK | 31 | Q96BW9 | |
| NYGNLASLGFLVAKP | 46 | Q6ZMY9 | |
| FPGVQTNISRKYGND | 111 | Q6ZN19 | |
| SPYGLSFNKGEVFRV | 531 | Q07157 | |
| ADGKRLSDYSIGPNS | 51 | P11441 | |
| GSTERYDQNYAGNKP | 121 | Q7L2R6 | |
| YRGQNPGDLRFNKGD | 136 | Q8TEC5 | |
| NDFKYGLIPGASNDF | 681 | Q96DT7 | |
| SRVNAKNPFFGYAGP | 426 | Q9Y2P4 | |
| DSLTGKFYNIGDQRG | 986 | Q7Z7G0 | |
| NYGRKGSASQVPSQA | 201 | O75604 | |
| PKFNSGSSDDVRYVN | 1201 | P17948 | |
| SIRNEGKLYPANFQG | 511 | P31629 | |
| PRFGNSQSFTSKYLG | 1681 | Q6N021 | |
| LLQFFKSQGYRDGPG | 836 | Q93009 | |
| SPYRKGSQCGEAFSQ | 6 | O60384 | |
| PDTGNSKGYAFINFA | 136 | Q15427 | |
| GKTRGGSPYNQFDII | 1426 | Q9UPQ9 | |
| TAPEKFLGDQRFSYG | 541 | Q9Y6N6 | |
| FRGRKDGYTESLNQP | 851 | Q8N1T3 | |
| KSPFYRAASGNEALG | 2456 | B2RTY4 |